WO2008013084A1 - Sugar-coated preparation and process for producing the same - Google Patents

Sugar-coated preparation and process for producing the same Download PDF

Info

Publication number
WO2008013084A1
WO2008013084A1 PCT/JP2007/064152 JP2007064152W WO2008013084A1 WO 2008013084 A1 WO2008013084 A1 WO 2008013084A1 JP 2007064152 W JP2007064152 W JP 2007064152W WO 2008013084 A1 WO2008013084 A1 WO 2008013084A1
Authority
WO
WIPO (PCT)
Prior art keywords
sugar
coating
coating liquid
coated
preparation
Prior art date
Application number
PCT/JP2007/064152
Other languages
French (fr)
Japanese (ja)
Inventor
Tatsuharu Shimokawa
Hiroyuki Kawashima
Original Assignee
Kowa Company, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Company, Ltd. filed Critical Kowa Company, Ltd.
Priority to CN2007800281535A priority Critical patent/CN101495101B/en
Priority to JP2008526734A priority patent/JPWO2008013084A1/en
Publication of WO2008013084A1 publication Critical patent/WO2008013084A1/en
Priority to HK09110763.5A priority patent/HK1132664A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Definitions

  • the present invention relates to a sugar-coated preparation and a method for producing the same.
  • the sugar-coated preparation has a function of preventing the permeation of oxygen, water, and odorous components from the sugar-coated layer. It is a dosage form suitable for conversion.
  • processed garlic has the effects of recovering fatigue and nourishing tones, enhancing gastric contractile force, promoting metabolism, promoting blood flow, protecting liver, etc. Many of them are made into sugar-coated products.
  • Methylmethioninesulfonium chloride (hereinafter also referred to as “MMSC”) is an improvement in subjective symptoms such as gastric ulcer, duodenal ulcer and gastritis and other findings, and liver function in chronic liver disease. It has the effect of alleviating various symptoms such as improvement, and is widely used as a medicine.
  • MMSC has the property of decomposing by absorbing moisture in the air
  • formulations containing MMSC have problems of quality degradation such as odor generation, discoloration, and decrease in the effective component content. is doing. For this reason, many MMSC preparations are sugar-coated preparations for the purpose of preventing moisture absorption (Patent Documents 1 and 2).
  • sodium valproate is also used in various epilepsies such as minor seizures 'focus seizures' psychomotor seizures and mixed seizures, personality behavioral disorders associated with epilepsy (e.g., moodiness / anger), and manic and manic depression. It is widely used as a therapeutic drug.
  • sodium valproate has hygroscopicity and deliquescence, and is formulated as a sugar coating for the purpose of preventing quality degradation after opening (Patent Documents 3 and 4).
  • Sugar coating preparations are generally produced by repeating [1] spraying of sugar coating liquid, [2] steaming, and [3] drying several times (for example, Patent Document 5).
  • [2] steaming is a process for completely filling the side of the sugar-coating preparation and spreading the sprayed sugar-coating liquid evenly on the plain tablets.
  • a sugar-coating liquid having a high viscosity is used, This is an indispensable process.
  • the manufacturing method of a sugar-coating preparation including a complicated process has disadvantages such as requiring a very long working time and requiring a large amount of sugar-coating liquid for the uncoated tablet.
  • Patent Document 1 Japanese Patent Application Laid-Open No. 2003-63953
  • Patent Document 2 Japanese Patent Laid-Open No. 2003-95928
  • Patent Document 3 Japanese Patent Application Laid-Open No. 2006-256961
  • Patent Document 4 Japanese Patent Laid-Open No. 04-235914
  • Patent Document 5 Japanese Patent Laid-Open No. 06-292511
  • Patent Document 6 Japanese Patent Laid-Open No. 56-87518
  • Patent Document 7 Japanese Unexamined Patent Application Publication No. 2004-155656
  • Patent Document 8 JP-A-49-133515
  • An object of the present invention is to provide a technique for producing a sugar-coating preparation having sufficient hardness and excellent in low hygroscopicity, deodorizing property and disintegration in a short time and simply.
  • it has a sugar-coating liquid that can be suitably used for the production of a sugar-coating preparation using a continuous coating method in which the spraying process and the drying process of the sugar-coating liquid are simultaneously performed, and a sugar-coating layer formed from this sugar-coating liquid. It is an object to provide a sugar-coated preparation and a method for producing the same.
  • a sugar-coating liquid prepared by mixing ethyl acrylate and methyl methacrylate copolymer in a specific ratio in a solvent containing sugar has physical properties suitable for the continuous coating method, and a sugar-coating liquid having such a composition. It was found that a sugar-coating preparation having a sugar-coating layer formed by a continuous coating method using a liquid has low hygroscopicity, deodorization and good disintegration, and has completed the present invention.
  • the present invention is a sugar coating liquid containing sugar, ethyl acrylate 'methyl methacrylate copolymer and a solvent, and the concentration power of ethyl acrylate' methyl methacrylate copolymer is 0.01 to 10% by weight based on the total solid content.
  • a sugar-coating liquid, a method of producing a sugar-coating preparation using the sugar-coating liquid, and a sugar-coating preparation obtained by this production method are provided.
  • FIG. 1 is a graph showing changes in moisture absorption rate of a sugar-coated preparation over time.
  • FIG. 2 is a graph showing changes in moisture absorption rate of a sugar coating preparation containing a processed garlic product and time.
  • FIG. 3 is a graph showing the change in moisture absorption rate of the MMSC-containing sugar-coated preparation over time.
  • FIG. 4 A graph showing changes in moisture absorption of a sugar-coated preparation containing sodium pulp oleate with time.
  • FIG. 5 is a graph showing the change in elution rate of time and the pulp oleate sodium.
  • the sugar-coating liquid of the present invention contains sugar, ethyl acrylate acrylate methyl methacrylate copolymer, and a solvent.
  • the sugar used in the present invention is a sugar that is usually used for forming a sugar coating layer of a sugar coating preparation.
  • the amount of sugar is not particularly limited, but it is usually 10 to 85% by weight, preferably 10 to 70% by weight, more preferably 15 to 60% by weight.
  • Ethyl acrylate 'methyl methacrylate copolymer used in the present invention is a polymer obtained by copolymerization of ethyl acrylate and methyl methacrylate.
  • the number average molecular weight of the copolymer may be in a range that can impart appropriate hardness and disintegration to the sugar-coated preparation, but is usually 10,000 to 1,500,000, preferably ⁇ 400,000 to 1,200. , 000, more preferred ⁇ should be between 500,000 and 1,100,000.
  • the molar ratio of ethyl acrylate and methyl methacrylate constituting the copolymer is usually 10: 1 to 1:10, preferably 4: 1 to 1: 4, more preferably 3: 1 to 1: 3. It is good.
  • the glass transition temperature of the copolymer is usually in the range of 40-30 ° C, preferably 1-30-20 ° C, more preferably 1-20 ° C.
  • Ethyl acrylate 'methyl methacrylate copolymer can be obtained by copolymerizing ethyl acrylate and methyl methacrylate according to a conventional method.
  • a commercially available product may be used as the ethyl acrylate acrylate and methyl methacrylate copolymer.
  • Examples of commercially available products include Eudragit NE30D (Higuchi Shokai) and Kollicoat EMM30D (BASF Japan), which are emulsions in which ethyl acrylate 'methyl methacrylate copolymer is dispersed in water using a surfactant. .
  • the blending amount of ethyl acrylate acrylate / methyl methacrylate copolymer is 0.01 to 10% by weight based on the total solid content in the sugar coating liquid. Among these, Preferably it is 0.1 to 8 weight%. If the blending amount exceeds 10% by weight, it may be suspended in the sugar coating liquid and the solid content may be agglomerated, which is preferable.
  • the mass ratio of ethyl acrylate acrylate / methyl methacrylate copolymer and sugar is usually 1: 1 to 1: 10,000, preferably 1: 3 to 1: 1,000, more preferably 1: 5 to 1: It should be 500!
  • the solvent for the sugar coating liquid of the present invention is not particularly limited as long as it is usually used for sugar coating liquid.
  • water, lower alcohols such as ethanol and isopropanol, acetone or a mixture thereof can be used.
  • purified water is usually preferably used.
  • the amount of the solvent in the sugar coating liquid is not particularly limited, but it is usually 15 to 90% by weight, preferably 15 to 85% by weight, and more preferably 20 to 80% by weight. If the amount of solvent exceeds 90% by weight, the working time for forming the sugar-coated layer becomes longer, and it may be difficult to form a dense sugar-coated layer, which may stabilize the drug contained in the core material. May affect sex. If it is less than 15% by weight, the viscosity of the sugar-coating liquid may become high, and there may be problems in workability such as the tablets adhering to the pan of the tablet coating device, and when a sugar-coating preparation is produced by the continuous coating method.
  • the sugar coating liquid does not spread uniformly on the tablet surface, and a uniform sugar coating layer cannot be formed.
  • the viscosity of the sugar-coating liquid is not limited as long as it can be sprayed by an apparatus used for manufacturing a sugar-coating preparation, but is usually 3 to 1, 0 OOcp, preferably 5 to 700 cp, more preferably 10 to 400 cp. In this way, the amount of solvent can be adjusted.
  • the sugar coating liquid of the present invention can contain various optional components that are acceptable as pharmaceutical additives and can be administered orally as desired.
  • additives include coating agents, colorants, and brighteners.
  • the coating agent include hydroxypropyl cellulose, hydroxypropyl methenoresenorelose 2910, hydroxypropino methenoresenorelose 2208, methinoresenolose, polybulol alcohol, polybulurpyrrolidone, crystalline cellulose, gum arabic powder, fine powder.
  • Shellac, pullulan, precipitated calcium carbonate, talc, calcium hydrogen phosphate, light anhydrous caustic acid, hydrous silicon dioxide, titanium oxide, sodium dihydrogen phosphate, hydrogenated oil, glyceryl monostearate and polyethylene glycol monostearate The blending amount is preferably 0 to 80% by weight based on the sugar coating liquid.
  • colorant examples include various edible pigments, tar pigments, and iron sesquioxide, and the blending amount thereof is preferably 0.1% by weight or less with respect to the sugar coating preparation.
  • the brightening agent examples include carnauba wax and beeswax.
  • the amount of the brightening agent is preferably 0.1% by weight or less based on the sugar-coating preparation.
  • the viscosity of the sugar coating liquid of the present invention is usually 3 to 1, OOOcp, preferably 5 to 700 cp, and more preferably 10 to 400 cp. When a sugar coating solution having such a viscosity is used, it is easy to form a uniform sugar coating layer even when a sugar coating preparation is produced by a continuous coating method.
  • the sugar-coating liquid of the present invention can be produced by suspending sugar, ethyl acrylate / methyl methacrylate copolymer and, if necessary, the above optional components in a solvent. At this time, it is also preferable to add a surfactant in order to sufficiently disperse the ethyl acrylate / methyl methacrylate copolymer in the solvent.
  • the sugar-coated preparation of the present invention has at least one sugar-coated layer formed by using the sugar-coating liquid of the present invention around the core material containing the drug.
  • Examples of the core material containing the drug contained in the sugar-coated preparation of the present invention include uncoated tablets and core granules. That is, the sugar-coated preparation of the present invention can be made into a sugar-coated tablet or a sugar-coated granule, for example.
  • the drug contained in the core material is a drug that has been confirmed to be safe by oral administration, and is not particularly limited as long as it is suitable for a sugar coating preparation, but preferably has an unpleasant odor.
  • drugs with an unpleasant odor include herbal medicines (such as oxoamidin powder, hops, quinceins, assemblies, carrots, carrots, wikiweeds, chioji, shokiyo and funnel extracts), processed garlic products, methylmethionine sulfone. -Umchloride, L-cysteine, vitamin B, etc.
  • Vitamin D Vitamin D, vitamin E, piotin, calcium pantothenate, nicotinamide, vitamin P and its derivatives
  • methylmethionine sulfo-um chloride amino acids (such as aspartic acid and L-cysteine), adenosine Phosphate ⁇ Sodium salt, enzymes (starch digestive enzyme, protein digestive enzyme, fat digestive enzyme and fibrin digestive enzyme, etc.), sodium valproate, ibuprofen, guaifenesin and butyl scopolamine bromide
  • drugs that generate ibuprofen, anhydrous caffeine, ethenamide, isopropylantipyrine, and L-menthol examples of drugs that generate ibuprofen, anhydrous caffeine, ethenamide, isopropylantipyrine, and L-menthol.
  • the compounding amount of the product can be appropriately adjusted according to the use of the drug, but is preferably 0.1 to 99% by weight, more preferably 1 to
  • examples of the drug contained in the core material preferably include the following drugs.
  • the processed garlic is obtained by subjecting bulbs of the allium sativum 1.
  • the processing method is not particularly limited, for example, raw garlic dried and powdered, raw garlic extracted with steam distillation, oil, water, hot water or water-soluble organic solvent, raw garlic What was processed by heating etc. can be used.
  • the oil used for extraction include edible vegetable oils such as rapeseed oil, olive oil, and soybean oil.
  • the water-soluble organic solvent include lower alcohols such as ethanol and isopropanol; Daricol such as propylene glycol and diethylene glycol.
  • As the garlic processed product those obtained by pulverization after drying, those extracted with a lower alcohol, and those processed by heating are particularly preferred.
  • the processed garlic product may be a commercial product.
  • processed oak, garlic extract, nin-ta extract, dried garlic and the like are particularly preferred.
  • the processed oat is a garlic powder obtained by drying an extract obtained by extracting heat-treated garlic with a lower alcohol, for example, oxoamidin (registered trademark) (manufactured by Riken Chemical Industry Co., Ltd.) and Oxo Resin (registered trademark) (manufactured by Riken Chemical Industry Co., Ltd.) is on the market.
  • the Ninta extract include Ninta extract (Alps Yakuhin Kogyo Co., Ltd.), Nin-ku extract (Nippon Powder Yakuhin Co., Ltd.) and the like.
  • garlic powder and roasted garlic powder EX are commercially available.
  • oxoamidin registered trademark
  • oxoresin registered trademark
  • garlic extract alps
  • garlic extract Nippon Powder Chemical Co., Ltd.
  • the amount of garlic processed product can be adjusted as appropriate according to the use of the sugar-coating preparation, but it is preferably 2 to 30% by weight, more preferably 5 to 15% by weight based on the core material. .
  • Methylmethionine sulfone chloride can be obtained according to a known production method. Further, as a commercial product, for example, methylmethionine sulfo-um chloride (manufactured by Yonezawa Hamari Chemical Co., Ltd., manufactured by Alps Pharmaceutical Co., Ltd.) is commercially available.
  • the blending amount of MMSC is preferably 1 to 80% by weight, more preferably 10 to 40% by weight with respect to the core material.
  • the core material containing MMSC has a component that neutralizes gastric acid, a component that suppresses secretion of gastric acid (antacid component), a component that enhances stomach function (healthy stomach component), and assists digestion It is also preferable to further contain a component (digestive enzyme), a component that repairs the gastric mucosa (mucosal repair component), and the like.
  • the antacid component synthetic hydrotalsart, sodium hydrogen carbonate, magnesium aluminate metasilicate, sodium hydroxide-aluminum sodium carbonate coprecipitate, funnel extract, sodium hydroxide aluminum, sodium hydrogen carbonate, Magnesium carbonate, precipitated calcium carbonate, precipitated magnesium carbonate, dihydroxyaluminum aminoacetate, magnesium hydroxide, magnesium oxide, dried aluminum hydroxide gel, magnesium bismuth silicate, magnesium silicate, synthetic aluminum silicate, Latidine hydrochloride, cimetidine, famotidine, nizatidine, lafutidine, omebrazole, lansoprazole, pantoprazole, rabebrazole sodium, leminoprazole, esomeprazole, pirenzepine hydrochloride, proglumi And the like.
  • the components of healthy stomach include: assembly powder, hop extract, gentian extract, wikiyo powder, shokiyo powder, chiyouji powder, akamegashi powder powder, acenic powder powder, turmeric powder powder, ubai powder powder, wook powder powder, wogon powder powder End, Katsuko End, Kanzo End, Kikoku End, Kina End, Kuzin End, Keihi End, Kemi Mei End, Genno Shoko End, Koujin End, Kobota End, Goshu End, Gobai End, Colombo End, Chimpi End, Hawthorn End, Hawthorn End , Sanna powder, Soshishi powder, Stasha powder, Shozuk powder, Sehi powder powder, Sekishokon powder powder, Soujutsu powder powder, Soyo powder, Daio powder powder, Chikusennin powder powder, Spruce powder powder,-Gaki powder powder,-Kukuk powder powder, Carrot powder powder, Hikokoshi End, hihatsu
  • Digestive enzymes include biodiastase, lipase, ursodeoxycholic acid, Examples include pussin, diasmen, cellulase, cell mouth sine, takadiastase, bile powder, dehydrochol, neurase, pancreatin, biotamirase, prozyme, and polypase.
  • Mucosal repair ingredients include sucralfate, aldioxa, L-glutamine, sofalcone, copper black mouth fin sodium, copper black mouth fin potassium, cetraxate hydrochloride, gefarnate, trimebutine maleate, sodium azulensulphonate, etc. Can be mentioned.
  • Sodium valproate can be obtained according to a known production method (for example, JP-A-60-156638, JP-A-62-160441, JP-A-63-122646, JP-A-10-130197). No. publication).
  • sodium valproate manufactured by Nippon Synthetic Chemical Industry, manufactured by Facebook
  • the blending amount of sodium valproate is preferably 1 to 80% by weight, more preferably 30 to 60% by weight based on the core material.
  • various optional components that can be administered orally can be blended in the core material as desired.
  • various optional additives that can be administered orally include excipients, binders, disintegrants, lubricants, and the like.
  • excipients examples include lactose, crystalline cellulose, sucrose, mannitol, light anhydrous carboxylic acid, calcium hydrogen phosphate, and corn starch.
  • binder examples include methyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, gelatin, polybutylpyrrolidone and pullulan.
  • disintegrant examples include carmellose calcium, low-substituted hydroxypropyl cellulose, crospovidone, and croscarmellose sodium.
  • Examples of the lubricant include magnesium stearate, calcium stearate and talc.
  • the core material used in the sugar-coated preparation of the present invention can be produced by a conventional method using a drug and other optional components.
  • a method of tableting the granulated product, or after granulating the drug to be blended and other optional additives are sized with a sizing machine to form powder, and if necessary, other optional additives are added to the powder and mixed to obtain powder, or these powders are tableted, or Examples thereof include a method in which a directly blended drug and other optional additives are mixed and tableted with a tableting machine.
  • examples of the granulation include a dry granulation method and a wet granulation method.
  • a powder is dry granulated without using a liquid such as water, ethanol, isopropanol, or a mixture thereof.
  • This is a method of producing a granular material by compression molding with a machine or the like to produce a plate-like solid material, and then breaking these.
  • the wet granulation method is a method in which a binding liquid is added to a powder by using a high speed stirring granulator, a kneading granulator, a fluidized bed granulator, a rolling fluid granulator, etc., to form particles.
  • the type of the binding solution is not particularly limited, but water, ethanol, isopropanol and a mixture thereof can be used.
  • the drug to be blended and other optional additives are granulated by a dry granulation method, a wet granulation method or a wet granulation method and an extrusion granulation method in combination.
  • a dry granulation method a wet granulation method or a wet granulation method and an extrusion granulation method in combination.
  • the method of condylar grain for example, the method of condylar grain.
  • At least one of the sugar coating layers covering the core material contained in the sugar coating preparation of the present invention is characterized in that it contains sugar and 0.01 to 10% by weight of ethyl acrylate / methyl methacrylate copolymer.
  • the sugar-coated preparation of the present invention has one or more coating layers formed of another coating liquid in addition to the one or more sugar-coated layers formed of the sugar coating liquid of the present invention. May be.
  • the layer formed from the sugar coating liquid of the present invention is referred to as “sugar coating layer”, and the layer formed from the sugar coating layer and the coating liquid other than the sugar coating liquid of the present invention is referred to as “coating layer”. May be described.
  • the covering layer is divided into a plurality of layers such as a protective layer, a subcoating layer, a smoothing layer, a coloring layer and a polishing layer according to the function. be able to.
  • the ratio of each of these layers to the entire coating layer is usually 0-20% for the waterproof layer, 15-100% for the undercoat layer, 0-50% for the midcoat layer, 0-50% for the overcoat layer, and the leach layer Is 0 to 10%.
  • a waterproof layer is applied to suppress moisture transfer to the core during the sugar coating process Is.
  • the undercoat layer is applied to shape the sugar-coated tablet, and the appearance and strength of the sugar-coated tablet are affected by the quality of the undercoat layer.
  • the intermediate layer is applied to smoothen the surface of the sugar-coated tablet, and the upper layer is colored to enhance the distinguishability and commercial value of the sugar-coated tablet.
  • the sugar-coated preparation of the present invention does not necessarily have to have all the coating layers having the above functions, but it is preferable to include a coating layer having the function of the undercoat layer.
  • the sugar-coating layer formed using the liquid can be suitably used as a coating layer having the function of an undercoat layer.
  • the sugar-coated preparation of the present invention can be covered with a release controlling layer in addition to the coating layer according to the purpose.
  • the release control layer is applied to give a function of controlling the dissolution of the drug contained in the core material, and may be one or a plurality of layers.
  • the release control layer can be applied directly to the core material, or it can be applied between any of the waterproof layer, undercoat layer, intermediate coat layer, overcoat layer, and leach layer. It is preferable to coat the core material.
  • 1 to 10% by weight is more preferable with respect to 1 part by weight of the sugar-coating preparation, more preferably 2 to 8% by weight.
  • conventional methods can be used as the method for applying the release controlling layer and the components used.
  • the weight of the sugar coating layer formed using the sugar coating liquid of the present invention in the sugar coating preparation of the present invention is preferably 5 to 60% by weight, more preferably 10 to 50% by weight, based on the weight of the core material. is there. If the weight of the sugar-coating layer exceeds 60% by weight, the coating process takes longer time, and the mass of the finished sugar-coating preparation increases with respect to the mass of the core material charged, resulting in the need for a separate coating device. . If the amount is less than 5% by weight, sufficient coating layer hardness cannot be obtained, and the coating layer is too thin to protect the contents such as uncoated tablets or core granules from environmental humidity. May occur.
  • the moisture absorption rate in the sugar-coated preparation of the present invention is preferably 1.0% or less, more preferably 0.5% or less under the conditions after 24 hours at a temperature and humidity of 25 ° C -85%. Under the condition after 30 days at a humidity of 40 ° C.-75%, it is preferably 4.0% or less, more preferably 3.0% or less.
  • the hardness and the degree of disintegration can be appropriately adjusted according to the intended use of the sugar-coated preparation of the present invention and the drug contained in the core material.
  • the hardness of the sugar-coated preparation is preferably 100N or more, more preferably 110N or more.
  • the degree of disintegration is preferably within 25 minutes.
  • the hardness of the sugar-coated preparation is preferably 65 N or more, more preferably 70 N or more.
  • the disintegration degree is preferably within 15 minutes.
  • the hardness of the sugar-coating preparation is preferably 65 N or more, more preferably 70 N or more.
  • the sugar-coated preparation of the present invention can be produced by forming a sugar-coated layer by a continuous coating method in which the step of spraying the sugar-coating liquid of the present invention and the drying step are simultaneously performed. That is, by spraying the sugar-coating liquid of the present invention on the core material containing the drug, drying is carried out, so that the solvent in the sugar-coating liquid covering the core material can be removed to form a sugar-coating layer. Also, depending on the core material used (plain tablet or core granule), a sugar-coated tablet or sugar-coated granule can be prepared.
  • a sugar coating layer covering the core material can be formed.
  • equipment used for the continuous coating method include a Neucoater (Freund Sangyo), Aqua Coater (Freund Sangyo), Palleta Coater (Paulek), and Doria Coater (Paulek).
  • the droplet size of the sugar coating liquid to be sprayed is preferably 0.1 to 1,000 m.
  • the spray amount is preferably adjusted to spread over the entire surface of the core material according to the size and amount of the core material. .
  • the temperature of the sugar coating liquid is preferably 10 to 80 ° C. It is preferable to adjust the supply air temperature and air volume so that the product temperature is 10-60 ° C! /.
  • a fluidized bed coating machine When producing sugar-coated granules, it is preferable to use a fluidized bed coating machine, and it is particularly desirable to use a rolling fluidized bed coating machine having a rotating disk at the bottom.
  • a fluidized bed coating machine For example, multiplex (Paurek), Darreux (Freund industry), Spiraflow (Freund industry), Agromaster (Hosokawamicron), and Numeralizer (non-nipadal).
  • Granules containing drugs in a coating device whose bottom surface of the main body rotates continuously, or Protease-coated granules with a waterproof layer, etc. are introduced, and a sugar coating layer covering the core material is formed by simultaneously spraying and drying the sugar coating liquid on the granules that flow and rotate in the apparatus or the protection-coated granules. be able to.
  • the droplet size of the sugar-coating liquid to be sprayed should be adjusted to 0.1 to LOO m so that the spray amount spreads over the entire surface of the core material according to the size and amount of the core material.
  • the temperature of the sugar coating liquid is preferably 10 to 80 ° C. It is preferable to adjust the supply air temperature and air volume so that the product temperature is 10-50 ° C.
  • the formation of the coating layer with a coating solution other than the sugar coating solution of the present invention can be carried out by a method generally used in the manufacture of sugar coating preparations.
  • the coating apparatus used at this time can be appropriately selected and used depending on the type of the coating solution, and is not particularly limited.
  • the droplets and spray amount when spraying the coating liquid can be adjusted in the same manner as the spraying of the sugar coating liquid.
  • the sugar-coated preparation of the present invention thus obtained has a sufficient hardness that the sugar-coated layer is thin compared to conventional preparations, and is excellent in low moisture absorption, deodorization and disintegration.
  • Lactose 3000g, hydroxypropylcellulose (HPC—L: Nippon Soda) 150g, corn starch 1200g, crystalline cellulose (Ceras PH—101: Asahi Kasei) lOOOg was put into a high-speed agitation granulator (VG—25: Baurek) and purified.
  • a granulated product was prepared by adding water. This was dried with a fluidized bed dryer (FLO-5B: Freund Sangyo), and then the dried product was sized with a sizing machine (Pair Mill, Showa Chemical Machinery).
  • the suspension was coated with a sugar coating liquid (Driacoater DRC-650, Norrec) and dried while spraying the sugar coating liquid to obtain 375 mg sugar coated tablets per tablet.
  • the suspension was coated with a sugar coating liquid (Driacoater DRC-650, Bauch) and dried while spraying the sugar coating liquid to obtain 375 mg sugar coated tablets per tablet. The time spent for the coating work was 2 hours.
  • the suspension was coated with a sugar coating liquid (Driacoater DRC-650, Norrec) and dried while spraying the sugar coating liquid to obtain 375 mg sugar coated tablets per tablet. The time spent on the coating work was 2 hours.
  • Suspended dragee solution consisting of 5160 g of protected latch obtained in Production Example 1, 1160 g of granulated sugar, 400 g of talc, 400 g of precipitated calcium carbonate, 40 g of hydroxypropylmethylcellulose 2910 (TC-5R: Shin-Etsu Chemical Co., Ltd.) and 2000 g of purified water
  • a coating machine Drycoater DRC-650, Norrec
  • the sugar coating solution was sprayed and dried to obtain 375 mg sugar coated tablets per tablet.
  • the time spent on coating is 2 hours. It was.
  • Protected tablet 5500g obtained in Production Example 1 was added to granulated sugar 1924g, talc 542g, precipitated canoresium carbonate 818g, gum arabic 64g, gelatin 30g, polyoxyethylene (105) polyoxypropylene (5) glycol (PEP-101: Freund Sangyo Co., Ltd.
  • a conventional sugar coating that uses a sugar coating liquid suspended in 22 g and 120 Og of purified water, and sprays, steams and drys the sugar coating liquid separately in a coating machine (Driacoater DRC-650, Paurek). According to the method, 445 mg of sugar-coated tablets were obtained per tablet. The time spent for the coating work was 6.5 hours.
  • Protected tablet 5500g obtained in Production Example 2 granulated sugar 1180g, talc 400g, precipitated calcium carbonate 400g, ethyl acrylate 'methyl methacrylate copolymer 30% dispersion (Eudragit NE30D: Higuchi Shokai) 66.7g and purified water 2000g
  • the sugar coating liquid is sprayed with a coating machine (Driacoater DRC-650, Norec) using the suspended sugar coating liquid consisting of Drying was carried out while fogging to obtain 375 mg sugar-coated tablets per tablet.
  • the time spent on the coating work was 2 hours.
  • Protected tablet 5500 g obtained in Production Example 2 granulated sugar 1160 g, talc 400 g, precipitated calcium carbonate 400 g, ethyl acrylate “methyl methacrylate copolymer 30% dispersion (Eudragit NE30D: Higuchi Shokai) 133.3 g and purified water 2000 g
  • the suspension was coated with a sugar coating liquid (Driacoater DRC-650, Norrec) and dried while spraying the sugar coating liquid to obtain 375 mg sugar coated tablets per tablet.
  • the time spent on the coating work was 2 hours.
  • Protected tablet 5500g obtained in Production Example 2 Granulated sugar 1120g, Talc 400g, Precipitated calcium carbonate 400g, Ethyl acrylate 'Methyl methacrylate copolymer 30% dispersion (Eudragit NE30D: Higuchi Shokai) 266.7g and purified water 2000g
  • the suspension was coated with a sugar coating liquid (Driacoater DRC-650, Norrec) and dried while spraying the sugar coating liquid to obtain 375 mg sugar coated tablets per tablet.
  • the time spent on the coating work was 2 hours.
  • Suspended sugar-coating liquid consisting of 1160 g of granulated sugar, 400 g of talc, 400 g of precipitated calcium carbonate, 40 g of hydroxypropylmethylcellulose 2910 (TC-5R: Shin-Etsu Chemical Co., Ltd.) and 2000 g of purified water
  • a coating machine Drycoater DRC-650, Norrec
  • the sugar coating solution was sprayed and dried to obtain 375 mg sugar coated tablets per tablet.
  • the time spent on the coating work was 2 hours.
  • Protected tablet 5500g obtained in Production Example 2 granulated sugar 1924g, talc 542g, precipitated canoresium carbonate 818g, gum arabic 64g, gelatin 30g, polyoxyethylene (105) polyoxypropylene (5) glycol (PEP-101: (Freund Sangyo Co., Ltd.)
  • a coating machine (Driacoater DRC-650 The sugar coating liquid was sprayed, steamed, and dried separately in Ulek), and 445 mg of sugar-coated tablets were obtained per tablet. The time spent for the coating work was 6.5 hours.
  • Methylmethioninesulfo-umchloride lOOOg (Methylmethiononesulfo-umchloride, Yonezawa Hamariyaku), lactose 600g, polybylpyrrolidone (Kollidon 30: BASF Japan) 300g, corn starch 1550g, carmellose calcium (ECG- 505: Gotoku (Pharmaceutical) 500g was put into a high-speed agitation granulator (VG-25: Paurek), and the granulated product was prepared by covering with ethanol. This was dried with a fluidized bed dryer (FLO-5B: Freund Sangyo), and then dried with a granulator (Power Mill, Showa Chemical Machinery).
  • FLO-5B Freund Sangyo
  • Protected lock obtained in Production Example 3 4800g, Granulated sugar 1180g, Talc 400g, Precipitated calcium carbonate 400g, Ethyl acrylate 'Methyl methacrylate copolymer 30% dispersion (Eudragit NE30D: Higuchi Shokai) 66.7g and purified water 2000g Using the sugar coating liquid suspended from the above, drying was performed while spraying the sugar coating liquid with a coating machine (Driacoater DRC-650, Norrec) to obtain 170 mg sugar coated tablets per tablet. The time spent on the coating work was one hour.
  • Protected tablet 4800g obtained in Production Example 3 was added to 1160g of granulated sugar, 400g of talc, 400g of precipitated calcium carbonate, 30% dispersion of ethyl acrylate and methyl methacrylate copolymer ( Eudragit NE30D: Higuchi Shokai) 133.
  • a suspension of sugar coating liquid consisting of 3 g and 2000 g of purified water, dry it while spraying the sugar coating liquid on a coating machine (Driacoater DRC-650, Norrec). 170 mg dragees were obtained per tablet. The time spent on the coating work was one hour.
  • Protected lock obtained in Production Example 3 4800g, Granulated sugar 1120g, Talc 400g, Precipitated calcium carbonate 400g, Ethyl acrylate 'Methyl methacrylate copolymer 30% dispersion (Eudragit NE30D: Higuchi Shokai) 266. 7g and purified water 2000g A coating machine (Driacoater DRC-650,
  • the powder was dried while spraying the sugar-coating liquid at REC) to obtain 170 mg of sugar-coated tablets per tablet.
  • the time spent on the coating work was one hour.
  • Suspended sugar-coating liquid consisting of 1800 g of granulated sugar, 400 g of talc, 400 g of precipitated calcium carbonate, 40 g of hydroxypropylmethylcellulose 2910 (TC-5R: Shin-Etsu Chemical Co., Ltd.) and 2000 g of purified water.
  • a coating machine Drycoater DRC-650, Norec
  • the time spent on the coating work was one hour.
  • the suspended sugar coating liquid consisting of 660 g of granulated sugar, 1100 g of talc, 1100 g of precipitated calcium carbonate, 280 g of gum arabic, 60 g of gelatin and 600 g of purified water, DRC-650, Norec
  • the time spent on the coating work was 3.5 hours.
  • a controlled release layer After applying a controlled release layer to the uncoated tablet using a coating machine (Driacoater DRC-6650, Norec), 60 g of ethyl cellulose and 30 g of light caustic anhydride were further dissolved in 141 Og of ethanol. Using the dispersed liquid, a controlled release layer was applied with a coating machine (Driacoater DRC-650, Purreck) to produce 245 mg controlled release tablets per tablet.
  • a coating machine Driacoater DRC-6650, Norec
  • a conventional sugar coating liquid consisting of 114 g of granulated sugar, 6 g of acid oxytitanium and 72 g of purified water is used to spray, steam and dry the sugar coating liquid separately on a small sugar coating machine (manufactured by Kikusui Seisakusho) According to the sugar coating method, 455 mg colored tablets per tablet were obtained. The time spent for this coating operation was 240 minutes.
  • a sugar coating liquid consisting of 15g of granulated sugar and 9g of purified water, spraying, steaming and drying the sugar coating liquid separately using a small sugar coating machine (manufactured by Kikusui Seisakusho) Dragee tablets (of which the sugar coat layer mass was 215 mg) were obtained. The time spent on this coating operation was 30 minutes, and the total time spent on all coating operations was 570 minutes.
  • the use of the production method of the present invention in which drying is performed simultaneously with spraying the sugar coating liquid can reduce the working time to one third or less compared with the conventional coating method. It was.
  • the weight of the sugar-coated layer in sugar-coated tablets can be reduced to about one-half to one-fourth.
  • Moisture absorption (%) (10 tablet weight after storage for each time-10 tablet weight at the start) Z 10 tablet weight at the start X 100
  • the sugar-coated preparations of Examples 1 to 3 had a low moisture absorption rate of 0.1% even when allowed to stand for 24 hours under the above conditions.
  • the sugar-coated preparation of Comparative Example 1 had a moisture absorption rate of 0.2% when allowed to stand for 3 hours, and increased to nearly 1.2% when allowed to stand for 24 hours.
  • Comparative example The sugar coating formulation of No. 2 increased the moisture absorption rate to about 0.5% when allowed to stand for 24 hours.
  • the sugar-coated preparations of Examples 4 to 6 showed a low moisture absorption rate of 0.1% even when allowed to stand for 24 hours under the above conditions.
  • the sugar-coated preparation of Comparative Example 3 had a moisture absorption rate of 0.4% when allowed to stand for 3 hours, and increased to nearly 2.1% when allowed to stand for 24 hours.
  • the sugar-coated preparation of Comparative Example 4 increased the moisture absorption rate to about 0.5% when allowed to stand for 24 hours.
  • the sugar-coated preparations of Examples 7 to 9 and Comparative Example 6 showed a low moisture absorption rate of 0.5% or less even when allowed to stand for 24 hours under the above conditions.
  • the sugar-coated preparation of Comparative Example 5 increased its moisture absorption rate to near 1.3% when left for 3 hours, and increased to near 5.6% when left for 24 hours.
  • the sugar-coated preparations of Examples 10 and 11 have a moisture absorption rate after 30 days, although the sugar-coated layer mass is about one-quarter and one-half that of Comparative Example 7, respectively. However, they were extremely low at 2.0% and 1.0% or less, respectively.
  • the sugar-coated preparation of Comparative Example 7 had a moisture absorption rate of nearly 4.0% after 7 days, and the tablet burst after 10 days. The rupture of the tablet is presumed to be due to the hygroscopic nature of sodium levoleate.
  • the sugar-coating liquid of the present invention when used, even when a sugar-coating preparation is produced by a coating method in which the sugar-coating liquid is dried while spraying the sugar-coating liquid, the sugar-coating is excellent in low hygroscopicity compared with the conventional sugar-coating preparation. It was possible to obtain a formulation.
  • the hardness and disintegration degree of the sugar-coated tablets obtained in Examples 1 to 9 and Comparative Examples 1 to 6 were measured.
  • the hardness was 20 tablets, and the tablet hardness was measured with a tablet hardness meter (PTB-311E manufactured by PHARMATEST) for each tablet, and the average value was calculated.
  • the degree of disintegration was measured using an auxiliary panel according to the disintegration test method described in the 15th revision of the Japanese Pharmacopoeia (disintegration tester manufactured by Toyama Sangyo Co., Ltd.). The test was conducted on 6 tablets and the average value was calculated. The results are shown in Tables 1-3.
  • Example 1 Example 2 Example 3 Comparative Example 1 Comparative Example 2 Hardness (N) 1 20.2 0.2 4 4 6 1 1 6. 1 7 1 .6 1 4 2 .7 Disintegration degree (min) 2 2 .4 2 1 .0 2 0 .6 2 9 .9 3 0 .9 [0063]
  • the sugar-coated preparations of Examples 1 to 3 had sufficient hardness and excellent disintegration properties.
  • the sugar-coated preparation of Comparative Example 1 was insufficient in both hardness and disintegration.
  • the sugar coating preparation of Comparative Example 2 had a high hardness and a poor disintegration property.
  • Example 4 Example 5 Example 6 Comparative Example 3 Comparative Example 4 Hardness (N) 1 1 8. 5 1 20. 3 1 2 5. 8 9 1. 8 1 3 8.5 Disintegration (min) 2 0. 5 2 2. 3 2 1. 9 2 8. 3 3 2. 1
  • the sugar-coated preparations of Examples 4 to 6 had sufficient hardness and excellent disintegration properties.
  • the sugar-coated preparation of Comparative Example 3 was insufficient in both hardness and disintegration.
  • the sugar-coating preparation of Comparative Example 4 had high and hardness! /, And the disintegration property was insufficient.
  • Example 7 Example 8 Example 9 Comparative Example 5 Comparative Example 6 Hardness (N) 7 2. 8 7 6. 5 8 1. 8 5 9. 8 9 2.9 Disintegration degree (min) 1 2. 1 1 1 .5 1 2. 2 1 1. 9 1 8. 5
  • the sugar-coated preparation of the present invention has sufficient hardness and excellent disintegration properties.
  • Example 4 Example 5 Example 6 Comparative Example 3 Comparative Example 4 Immediately after production 0 0 0 0 0 0 0
  • Example 7 Example 8
  • Example 7 Example 8
  • Example 9 Comparative example 5 Comparative example 6
  • Moisture value (%) 1.6 5 1.5 5 5 5 1.6 2 1.5 5 6 2.4 8
  • the dissolution test of the sugar-coated tablets of Example 11 was performed. The test was conducted at lOOrpm per minute using the Japanese Pharmacopoeia Dissolution Test Method 2 (Paddle Method) using 500 mL of the Japanese Pharmacopoeia General Test Method Disintegration Test Method 2 as the test solution. Sampling was performed every hour, and sodium valproate in the sampling solution was quantified by HPLC, and the elution rate (%) of sodium pulp oleate was calculated. The results are shown in FIG.
  • FIG. 5 shows that the sugar-coated preparation of the present invention is also excellent in sustained release properties.
  • the sugar-coating liquid of the present invention is also useful for making a sugar-coating preparation of a drug that requires sustained release.
  • the sugar-coated preparation of the present invention is a preparation that has sufficient hardness and is excellent in low hygroscopicity and deodorization as compared with conventional sugar-coated preparations produced by a continuous coating method. Compared with conventional sugar-coating preparations manufactured by the method, it was found that the preparations can be manufactured with a short coating process, have a low water content immediately after manufacture, and have excellent disintegration properties.
  • a sugar-coating preparation having sufficient hardness despite its thin sugar-coating layer and excellent in low moisture, low hygroscopicity, disintegration, and deodorization immediately after production can be obtained in a short time. And it can manufacture easily.
  • the sugar-coating liquid of the present invention By using the sugar-coating liquid of the present invention, it is possible to produce a sugar-coating preparation by a continuous coating method in which the spraying process and the drying process of the sugar-coating liquid are performed simultaneously. That is, a sugar-coating preparation excellent in low oxygen permeability, low hygroscopicity, deodorization and disintegration can be produced in a short time without requiring a complicated process.
  • the production method of the present invention forms a thin sugar coating layer. Therefore, it greatly contributes to reducing the amount of sugar-coating liquid used and miniaturizing the preparation.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A technique for producing a sugar-coated preparation which has sufficient hardness and is excellent in low moisture absorption, a deodorizing property and disintegratability easily in a short time is provided. Specifically, a sugar-coating liquid which can be preferably used in the production of a sugar-coated preparation using a continuous coating method in which a step of spraying the sugar-coating liquid and a drying step are simultaneously conducted, a sugar-coated preparation with a sugar-coating layer formed with the sugar-coating liquid, and a process for producing the same are provided. The sugar-coated preparation is produced using the sugar-coating liquid containing an ethyl acrylate/methyl methacrylate copolymer and a solvent wherein the concentration of the ethyl acrylate/methyl methacrylate copolymer is 0.01 to 10% by weight based on the total solid component.

Description

明 細 書  Specification
糖衣製剤およびその製造方法  Sugar coating preparation and method for producing the same
技術分野  Technical field
[0001] 本発明は、糖衣製剤及びその製造方法に関する。  [0001] The present invention relates to a sugar-coated preparation and a method for producing the same.
背景技術  Background art
[0002] 糖衣製剤は、その糖衣層が酸素、水、臭い成分の透過を防ぐ機能を有することから 、低酸素透過性、低吸湿性、防臭性に優れ、素錠に配合される成分の安定化に適し た剤形である。  [0002] The sugar-coated preparation has a function of preventing the permeation of oxygen, water, and odorous components from the sugar-coated layer. It is a dosage form suitable for conversion.
[0003] 例えば、ニンニク加工物は、疲労回復や滋養強壮効果の他、胃収縮力増強作用、 新陳代謝促進作用、血流促進作用、肝保護作用等があり医薬品として汎用されてい る力 熱や水分の影響で臭いを発するため、その多くが糖衣製剤化されている。 また、メチノレメチォニンスノレホニゥムクロライド(Methylmethioninesulfonium chloride 以下、「MMSC」ともいう。)は、胃潰瘍、十二指腸潰瘍、胃炎等の自覚症状及び他覚 所見の改善、慢性肝疾患における肝機能の改善等の諸症状の緩和等の作用を有し 、医薬品として汎用されている。し力しながら、 MMSCは空気中の水分を吸収すること により分解する性質を有するため、 MMSCを含む製剤は、臭いの発生、変色、有効成 分の含量の低下などの品質低下の問題を有している。そのため、吸湿を防止する目 的で MMSC製剤の多くは糖衣製剤化されて 、る (特許文献 1、 2)。  [0003] For example, processed garlic has the effects of recovering fatigue and nourishing tones, enhancing gastric contractile force, promoting metabolism, promoting blood flow, protecting liver, etc. Many of them are made into sugar-coated products. Methylmethioninesulfonium chloride (hereinafter also referred to as “MMSC”) is an improvement in subjective symptoms such as gastric ulcer, duodenal ulcer and gastritis and other findings, and liver function in chronic liver disease. It has the effect of alleviating various symptoms such as improvement, and is widely used as a medicine. However, because MMSC has the property of decomposing by absorbing moisture in the air, formulations containing MMSC have problems of quality degradation such as odor generation, discoloration, and decrease in the effective component content. is doing. For this reason, many MMSC preparations are sugar-coated preparations for the purpose of preventing moisture absorption (Patent Documents 1 and 2).
また、バルプロ酸ナトリウムは、小発作'焦点発作'精神運動発作ならびに混合発作 等の各種てんかん、てんかんに伴う性格行動障害 (不機嫌 ·易怒性等)、及び躁病お よび躁うつ病の躁状態の治療用の医薬品として汎用されている。しかしながら、バル プロ酸ナトリウムは吸湿性と潮解性を有しており、開封後の品質低下を防止する目的 で糖衣製剤化されて 、る (特許文献 3、 4)。  Sodium valproate is also used in various epilepsies such as minor seizures 'focus seizures' psychomotor seizures and mixed seizures, personality behavioral disorders associated with epilepsy (e.g., moodiness / anger), and manic and manic depression. It is widely used as a therapeutic drug. However, sodium valproate has hygroscopicity and deliquescence, and is formulated as a sugar coating for the purpose of preventing quality degradation after opening (Patent Documents 3 and 4).
[0004] 糖衣製剤は、一般的には、 [1]糖衣液の噴霧、 [2]蒸らし、 [3]乾燥を数回繰り返 すことにより製造される(例えば、特許文献 5)。このうち [2]蒸らしは、糖衣製剤の側 面部を完全に埋め、噴霧した糖衣液を素錠上に均一に広げるための工程であり、通 常高い粘度を有する糖衣液を用いる場合には、不可欠な工程である。一方、このよう な工程を含む糖衣製剤の製造方法は、非常に長い作業時間を要し、素錠に対して 多量の糖衣液を要するなどの不利な面がある。 [0004] Sugar coating preparations are generally produced by repeating [1] spraying of sugar coating liquid, [2] steaming, and [3] drying several times (for example, Patent Document 5). Of these, [2] steaming is a process for completely filling the side of the sugar-coating preparation and spreading the sprayed sugar-coating liquid evenly on the plain tablets. Usually, when a sugar-coating liquid having a high viscosity is used, This is an indispensable process. On the other hand, like this The manufacturing method of a sugar-coating preparation including a complicated process has disadvantages such as requiring a very long working time and requiring a large amount of sugar-coating liquid for the uncoated tablet.
[0005] 上記の不利な面を克服する製造方法としては、フィルムコーティング錠の製造のよう に、コーティング液を噴霧しながら乾燥を行ってコーティング層を形成する方法 (以下 、連続コーティング法ともいう。 )により糖衣層を形成する方法が検討されている。連 続コーティング法では、噴霧した糖衣液を速やかに均一に、素錠等の芯材上に広げ なければならないため、糖衣液を希釈して粘度を低くすることが求められる。そこで、 例えば、糖とタルクを懸濁した糖衣液を用いて薄層糖衣層を形成する技術等が開発 された (特許文献 6)。し力しながら、このような薄層糖衣層は、従来品に比べて強度 が劣るという問題があった。また、薄層糖衣層の強度を改善する方法として、例えば フィルムコーティング錠と糖衣層の間に中間層を設ける技術等も開発された (特許文 献 7)。しカゝしながらこのような方法は、糖衣層と異なる組成を有するコーティング液の 調製、噴霧を含むため十分に簡便なものとは言い難力 た。また、通常結合剤として 用いられるアラビアゴムやゼラチンの代わりに、ヒドロキシプロピルメチルセルロースや ヒドロキシプロピルセルロースを使用して、糖衣液の粘度を低下する技術も開発され ている(特許文献 8)。し力しながらこの方法によって得られた糖衣層は、緻密性が十 分ではなぐ糖衣製剤の特徴である低酸素透過性、低吸湿性、防臭性に劣るという 問題があった。  [0005] As a production method for overcoming the above disadvantages, a method of forming a coating layer by drying while spraying a coating liquid, as in the production of a film-coated tablet (hereinafter also referred to as a continuous coating method). ), A method of forming a sugar coating layer is being studied. In the continuous coating method, since the sprayed sugar coating solution must be spread quickly and uniformly on a core material such as an uncoated tablet, it is required to dilute the sugar coating solution to reduce the viscosity. Therefore, for example, a technique for forming a thin sugar coating layer using a sugar coating solution in which sugar and talc are suspended has been developed (Patent Document 6). However, such a thin sugar-coated layer has a problem that it is inferior in strength to the conventional product. In addition, as a method for improving the strength of the thin sugar coating layer, for example, a technique of providing an intermediate layer between the film-coated tablet and the sugar coating layer has been developed (Patent Document 7). However, such a method is difficult to say because it involves the preparation and spraying of a coating solution having a composition different from that of the sugar coating layer. In addition, a technique for reducing the viscosity of a sugar coating liquid by using hydroxypropylmethylcellulose or hydroxypropylcellulose instead of gum arabic or gelatin usually used as a binder has been developed (Patent Document 8). However, the sugar-coated layer obtained by this method has a problem that it is inferior in low oxygen permeability, low hygroscopicity, and deodorizing properties, which are characteristics of a sugar-coated preparation that is not sufficiently dense.
このように、糖衣製剤の製造方法や糖衣液については、作業性及び製剤の特性の 改善の両面から種々の検討が行われているものの、両者を共に改善する技術は未 だ開発されていない。  As described above, various investigations have been made on the method for producing a sugar-coating preparation and the sugar-coating liquid from the viewpoint of improving workability and the characteristics of the preparation, but a technology for improving both of them has not been developed yet.
[0006] 特許文献 1 :特開 2003— 63953号公報 [0006] Patent Document 1: Japanese Patent Application Laid-Open No. 2003-63953
特許文献 2:特開 2003 - 95928号公報  Patent Document 2: Japanese Patent Laid-Open No. 2003-95928
特許文献 3:特開 2006 - 256961号公報  Patent Document 3: Japanese Patent Application Laid-Open No. 2006-256961
特許文献 4:特開平 04 - 235914号公報  Patent Document 4: Japanese Patent Laid-Open No. 04-235914
特許文献 5:特開平 06— 292511号公報  Patent Document 5: Japanese Patent Laid-Open No. 06-292511
特許文献 6:特開昭 56— 87518号公報  Patent Document 6: Japanese Patent Laid-Open No. 56-87518
特許文献 7 :特開 2004— 155656号公報 特許文献 8:特開昭 49 - 133515号公報 Patent Document 7: Japanese Unexamined Patent Application Publication No. 2004-155656 Patent Document 8: JP-A-49-133515
発明の開示  Disclosure of the invention
[0007] 本発明は、十分な硬度を有し、かつ低吸湿性、防臭性、崩壊性に優れる糖衣製剤 を短時間かつ簡易に製造する技術を提供することを課題とする。具体的には、糖衣 液の噴霧工程、及び乾燥工程を同時に行う連続コーティング法を用いた糖衣製剤の 製造に好適に用いることができる糖衣液、この糖衣液により形成された糖衣層を有す る糖衣製剤及びその製造方法を提供することを課題とする。  [0007] An object of the present invention is to provide a technique for producing a sugar-coating preparation having sufficient hardness and excellent in low hygroscopicity, deodorizing property and disintegration in a short time and simply. Specifically, it has a sugar-coating liquid that can be suitably used for the production of a sugar-coating preparation using a continuous coating method in which the spraying process and the drying process of the sugar-coating liquid are simultaneously performed, and a sugar-coating layer formed from this sugar-coating liquid. It is an object to provide a sugar-coated preparation and a method for producing the same.
[0008] 本発明者らは、連続コーティング法に好適な糖衣液の組成にっ ヽて、種々の検討 を行った。そして、糖を含む溶剤に、アクリル酸ェチル 'メタクリル酸メチルコポリマー を特定の割合で配合した糖衣液が、連続コーティング法に適した物性を有して ヽるこ と、このような組成を有する糖衣液を用いた連続コーティング法により形成された糖衣 層を有する糖衣製剤は、低吸湿性、防臭性、及び良好な崩壊性を備えていることを 見出し、本発明を完成するに至った。  [0008] The present inventors have conducted various studies on the composition of a sugar coating liquid suitable for the continuous coating method. A sugar-coating liquid prepared by mixing ethyl acrylate and methyl methacrylate copolymer in a specific ratio in a solvent containing sugar has physical properties suitable for the continuous coating method, and a sugar-coating liquid having such a composition. It was found that a sugar-coating preparation having a sugar-coating layer formed by a continuous coating method using a liquid has low hygroscopicity, deodorization and good disintegration, and has completed the present invention.
すなわち、本発明は糖、アクリル酸ェチル 'メタクリル酸メチルコポリマー及び溶媒を 含む糖衣液であって、アクリル酸ェチル 'メタクリル酸メチルコポリマーの濃度力 全 固形分に対して 0. 01〜10重量%である糖衣液、該糖衣液を用いて糖衣製剤を製 造する方法、及びこの製造方法により得られた糖衣製剤を提供するものである。 図面の簡単な説明  That is, the present invention is a sugar coating liquid containing sugar, ethyl acrylate 'methyl methacrylate copolymer and a solvent, and the concentration power of ethyl acrylate' methyl methacrylate copolymer is 0.01 to 10% by weight based on the total solid content. A sugar-coating liquid, a method of producing a sugar-coating preparation using the sugar-coating liquid, and a sugar-coating preparation obtained by this production method are provided. Brief Description of Drawings
[0009] [図 1]時間の経過と糖衣製剤の吸湿率の変化を示す図である。 [0009] FIG. 1 is a graph showing changes in moisture absorption rate of a sugar-coated preparation over time.
[図 2]時間の経過とニン-ク加工物含有糖衣製剤の吸湿率の変化を示す図である。  FIG. 2 is a graph showing changes in moisture absorption rate of a sugar coating preparation containing a processed garlic product and time.
[図 3]時間の経過と MMSC含有糖衣製剤の吸湿率の変化を示す図である。  FIG. 3 is a graph showing the change in moisture absorption rate of the MMSC-containing sugar-coated preparation over time.
[図 4]時間の経過とパルプ口酸ナトリウム含有糖衣製剤の吸湿率の変化を示す図であ る。  [Fig. 4] A graph showing changes in moisture absorption of a sugar-coated preparation containing sodium pulp oleate with time.
[図 5]時間の経過とパルプ口酸ナトリウムの溶出率の変化を示す図である。  FIG. 5 is a graph showing the change in elution rate of time and the pulp oleate sodium.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0010] 本発明の糖衣液は、糖、アクリル酸ェチル 'メタクリル酸メチルコポリマー、及び溶剤 を含む。 [0010] The sugar-coating liquid of the present invention contains sugar, ethyl acrylate acrylate methyl methacrylate copolymer, and a solvent.
本発明で用いる糖は、通常糖衣製剤の糖衣層の形成に用いられる糖であれば特 に制限なく用いることができ、例えば、グラニュー糖、精製白糖、白糖、ブドウ糖、トレ ノ、ロースなどが挙げられる。この中でも、グラニュー糖、精製白糖、白糖を好ましく用 いることがでさる。 The sugar used in the present invention is a sugar that is usually used for forming a sugar coating layer of a sugar coating preparation. Can be used without limitation, and examples thereof include granulated sugar, purified sucrose, sucrose, glucose, toreno, and loin. Of these, granulated sugar, purified sucrose, and sucrose are preferably used.
本発明の糖衣液において、糖の配合量は特に制限されないが、通常 10〜85重量 %、好ましくは 10〜70重量%、さらに好ましくは 15〜60重量%とするのがよい。  In the sugar coating liquid of the present invention, the amount of sugar is not particularly limited, but it is usually 10 to 85% by weight, preferably 10 to 70% by weight, more preferably 15 to 60% by weight.
[0011] 本発明で用いるアクリル酸ェチル 'メタクリル酸メチルコポリマーとは、アクリル酸ェ チルとメタクリル酸メチルが共重合したポリマーである。コポリマーの数平均分子量は 、糖衣製剤に適切な硬度及び崩壊性を付与しうる範囲であればよいが、通常は 10, 000〜1, 500, 000、好まし <は 400, 000〜1, 200, 000、さらに好まし <は 500, 000〜1, 100, 000であるのがよい。また、コポリマーを構成するアクリル酸ェチルと メタクリル酸メチルのモル比は、通常は10 : 1〜1 : 10、好ましくは 4 : 1〜1 :4、さらに 好ましくは 3 : 1〜1: 3であるのがよい。また、コポリマーのガラス転移温度は、通常は 40〜30°C、好ましくは一 30〜20°C、さらに好ましくは一 20〜10°Cの範囲である のがよい。 [0011] Ethyl acrylate 'methyl methacrylate copolymer used in the present invention is a polymer obtained by copolymerization of ethyl acrylate and methyl methacrylate. The number average molecular weight of the copolymer may be in a range that can impart appropriate hardness and disintegration to the sugar-coated preparation, but is usually 10,000 to 1,500,000, preferably <400,000 to 1,200. , 000, more preferred <should be between 500,000 and 1,100,000. Further, the molar ratio of ethyl acrylate and methyl methacrylate constituting the copolymer is usually 10: 1 to 1:10, preferably 4: 1 to 1: 4, more preferably 3: 1 to 1: 3. It is good. The glass transition temperature of the copolymer is usually in the range of 40-30 ° C, preferably 1-30-20 ° C, more preferably 1-20 ° C.
アクリル酸ェチル 'メタクリル酸メチルコポリマーは、アクリル酸ェチルとメタクリル酸メ チルを常法に従って共重合させることにより得ることができる。また、アクリル酸ェチル 'メタクリル酸メチルコポリマーは、市販品を用いてもよい。市販品としては、例えば、 アクリル酸ェチル 'メタクリル酸メチルコポリマーを界面活性剤を用いて水に分散させ た乳濁液であるオイドラギット NE30D (樋口商会)、コリコート EMM30D (BASFジャ パン)などが挙げられる。  Ethyl acrylate 'methyl methacrylate copolymer can be obtained by copolymerizing ethyl acrylate and methyl methacrylate according to a conventional method. A commercially available product may be used as the ethyl acrylate acrylate and methyl methacrylate copolymer. Examples of commercially available products include Eudragit NE30D (Higuchi Shokai) and Kollicoat EMM30D (BASF Japan), which are emulsions in which ethyl acrylate 'methyl methacrylate copolymer is dispersed in water using a surfactant. .
本発明の糖衣液において、アクリル酸ェチル 'メタクリル酸メチルコポリマーの配合 量は、糖衣液中に含まれる全固形分に対して 0. 01〜10重量%である。この中でも、 好ましくは 0. 1〜8重量%である。配合量が 10重量%を超えると糖衣液中に懸濁し て 、る固形分の凝集が生じることがあり好ましくな 、。  In the sugar coating liquid of the present invention, the blending amount of ethyl acrylate acrylate / methyl methacrylate copolymer is 0.01 to 10% by weight based on the total solid content in the sugar coating liquid. Among these, Preferably it is 0.1 to 8 weight%. If the blending amount exceeds 10% by weight, it may be suspended in the sugar coating liquid and the solid content may be agglomerated, which is preferable.
本発明の糖衣液において、アクリル酸ェチル 'メタクリル酸メチルコポリマー及び糖 の質量比は、通常1 : 1〜1 : 10, 000、好ましくは1 : 3〜1 : 1, 000、さらに好ましくは 1: 5〜1: 500とすることがよ!、。  In the sugar coating liquid of the present invention, the mass ratio of ethyl acrylate acrylate / methyl methacrylate copolymer and sugar is usually 1: 1 to 1: 10,000, preferably 1: 3 to 1: 1,000, more preferably 1: 5 to 1: It should be 500!
[0012] 本発明の糖衣液の溶剤としては、通常糖衣液に用いられるものであれば特に制限 されない。例えば、水、エタノール、イソプロパノール等の低級アルコール、アセトン 又はそれらの混合物が挙げられる。これらの溶剤の中では、通常精製水が好ましく用 いられる。 [0012] The solvent for the sugar coating liquid of the present invention is not particularly limited as long as it is usually used for sugar coating liquid. Not. For example, water, lower alcohols such as ethanol and isopropanol, acetone or a mixture thereof can be used. Of these solvents, purified water is usually preferably used.
糖衣液中の溶剤の配合量は、特に制限されないが、通常 15〜90重量%、好ましく は 15〜85重量%、さらに好ましくは 20〜80重量%とするのがよい。溶剤の配合量 力 S90重量%を超えると、糖衣層を形成するための作業時間が長くなると共に、緻密 な糖衣層を形成することが困難となる場合があり、芯材に含有した薬物の安定性に 影響を及ぼすことがある。また 15重量%未満だと糖衣液の粘性が高くなる場合があり 、錠剤コーティング装置のパンに錠剤が付着するなど作業性に問題があり、また、連 続コーティング法により糖衣製剤を製造する場合に錠剤表面に均一に糖衣液が行き 渡らず、均一な厚みの糖衣層が形成できないことがある。また、糖衣液の粘度は、糖 衣製剤の製造に用いる装置により噴霧が可能な範囲であればよいが、通常 3〜1, 0 OOcp、好ましくは 5〜700cp、さらに好ましくは 10〜400cpとなるように溶剤の酉己合 量を調節することもできる。  The amount of the solvent in the sugar coating liquid is not particularly limited, but it is usually 15 to 90% by weight, preferably 15 to 85% by weight, and more preferably 20 to 80% by weight. If the amount of solvent exceeds 90% by weight, the working time for forming the sugar-coated layer becomes longer, and it may be difficult to form a dense sugar-coated layer, which may stabilize the drug contained in the core material. May affect sex. If it is less than 15% by weight, the viscosity of the sugar-coating liquid may become high, and there may be problems in workability such as the tablets adhering to the pan of the tablet coating device, and when a sugar-coating preparation is produced by the continuous coating method. In some cases, the sugar coating liquid does not spread uniformly on the tablet surface, and a uniform sugar coating layer cannot be formed. The viscosity of the sugar-coating liquid is not limited as long as it can be sprayed by an apparatus used for manufacturing a sugar-coating preparation, but is usually 3 to 1, 0 OOcp, preferably 5 to 700 cp, more preferably 10 to 400 cp. In this way, the amount of solvent can be adjusted.
本発明の糖衣液には、上記の各成分以外に、医薬の添加物として許容され、かつ 経口投与可能な各種任意成分を所望に応じて配合する事が可能である。そのような 添加剤として、例えば、コーティング剤、着色剤及び光沢化剤などが挙げられる。 コーティング剤としては、例えば、ヒドロキシプロピルセルロース、ヒドロキシプロピル メチノレセノレロース 2910、ヒドロキシプロピノレメチノレセノレロース 2208、メチノレセノレロー ス、ポリビュルアルコール、ポリビュルピロリドン、結晶セルロース、アラビアゴム末、精 製セラック、プルラン、沈降炭酸カルシウム、タルク、リン酸水素カルシウム、軽質無水 ケィ酸、含水二酸化ケイ素、酸化チタン、リン酸二水素ナトリウム、硬化油、モノステア リン酸グリセリル及びモノステアリン酸ポリエチレングリコールなどがあり、その配合量 は、糖衣液に対して 0〜80重量%が好ましい。  In addition to the above-described components, the sugar coating liquid of the present invention can contain various optional components that are acceptable as pharmaceutical additives and can be administered orally as desired. Examples of such additives include coating agents, colorants, and brighteners. Examples of the coating agent include hydroxypropyl cellulose, hydroxypropyl methenoresenorelose 2910, hydroxypropino methenoresenorelose 2208, methinoresenolose, polybulol alcohol, polybulurpyrrolidone, crystalline cellulose, gum arabic powder, fine powder. Shellac, pullulan, precipitated calcium carbonate, talc, calcium hydrogen phosphate, light anhydrous caustic acid, hydrous silicon dioxide, titanium oxide, sodium dihydrogen phosphate, hydrogenated oil, glyceryl monostearate and polyethylene glycol monostearate The blending amount is preferably 0 to 80% by weight based on the sugar coating liquid.
着色剤としては、例えば、各種食用色素、タール色素及び三二酸化鉄などがあり、 その配合量は、糖衣製剤に対して 0. 1重量%以下であることが好ましい。  Examples of the colorant include various edible pigments, tar pigments, and iron sesquioxide, and the blending amount thereof is preferably 0.1% by weight or less with respect to the sugar coating preparation.
光沢化剤としては、例えば、カルナウパロウやミツロウなどがあり、その配合量は糖 衣製剤に対して 0. 1重量%以下であることが好ましい。 [0014] また、本発明の糖衣液の粘度は、通常 3〜1, OOOcp、好ましくは 5〜700cp、さら に好ましくは 10〜400cpであるのがよい。このような範囲の粘度の糖衣液を用いれ ば、連続コーティング法により糖衣製剤を製造する場合においても、均一な糖衣層を 形成することが容易となる。 Examples of the brightening agent include carnauba wax and beeswax. The amount of the brightening agent is preferably 0.1% by weight or less based on the sugar-coating preparation. [0014] The viscosity of the sugar coating liquid of the present invention is usually 3 to 1, OOOcp, preferably 5 to 700 cp, and more preferably 10 to 400 cp. When a sugar coating solution having such a viscosity is used, it is easy to form a uniform sugar coating layer even when a sugar coating preparation is produced by a continuous coating method.
本発明の糖衣液は、糖、アクリル酸ェチル 'メタクリル酸メチルコポリマー及び必要 に応じて上記任意成分を溶剤に懸濁することにより製造することができる。この際、ァ クリル酸ェチル 'メタクリル酸メチルコポリマーを溶媒中に十分に分散させるために、 界面活性剤を加えることも好ま ヽ。  The sugar-coating liquid of the present invention can be produced by suspending sugar, ethyl acrylate / methyl methacrylate copolymer and, if necessary, the above optional components in a solvent. At this time, it is also preferable to add a surfactant in order to sufficiently disperse the ethyl acrylate / methyl methacrylate copolymer in the solvent.
[0015] 本発明の糖衣製剤は、薬物を含む芯材の周りに、本発明の糖衣液を用いて形成し た糖衣層を少なくとも 1つ有する。 [0015] The sugar-coated preparation of the present invention has at least one sugar-coated layer formed by using the sugar-coating liquid of the present invention around the core material containing the drug.
本発明の糖衣製剤に含まれる薬物を含む芯材としては、素錠や芯顆粒が挙げられ る。すなわち本発明の糖衣製剤は、例えば糖衣錠や糖衣顆粒の剤形とすることがで きる。  Examples of the core material containing the drug contained in the sugar-coated preparation of the present invention include uncoated tablets and core granules. That is, the sugar-coated preparation of the present invention can be made into a sugar-coated tablet or a sugar-coated granule, for example.
本発明において、芯材に含有される薬物としては、経口投与による安全性が確認さ れている薬物であり、糖衣製剤に適したものであれば特に制限されないが、好ましく は、不快な臭いを有する薬物、水分に不安定な薬物、ゥイスカーを発生する薬物な どが挙げられる。例えば、不快な臭いを有する薬物としては生薬 (ォキソアミヂン末、 ホップ、ョクイ-ン、センブリ、ニンジン、ォウギ、ウイキヨウ、チヨウジ、ショウキヨウ及び ロートエキスなど)、ニン-ク加工物、メチルメチォニンスルホ -ゥムクロライド、 L—シ スティン及びビタミン B類などが挙げられ、水分に不安定な薬物としては各種ビタミン  In the present invention, the drug contained in the core material is a drug that has been confirmed to be safe by oral administration, and is not particularly limited as long as it is suitable for a sugar coating preparation, but preferably has an unpleasant odor. Drugs that have moisture, drugs that are unstable to water, and drugs that generate whiskers. For example, drugs with an unpleasant odor include herbal medicines (such as oxoamidin powder, hops, quinceins, assemblies, carrots, carrots, wikiweeds, chioji, shokiyo and funnel extracts), processed garlic products, methylmethionine sulfone. -Umchloride, L-cysteine, vitamin B, etc.
1  1
(ビタミン A類、ビタミン B類、ビタミン B類、ビタミン B類、ビタミン B 類、ビタミン C類  (Vitamin A, Vitamin B, Vitamin B, Vitamin B, Vitamin B, Vitamin C
1 2 6 12  1 2 6 12
、ビタミン D類、ビタミン E類、ピオチン、パントテン酸カルシウム、ニコチン酸アミド、ビ タミン P及びその誘導体など)、メチルメチォニンスルホ -ゥムクロライド、アミノ酸類( ァスパラギン酸及び L—システィンなど)、アデノシン三リン酸 · 2ナトリウム塩、酵素(で んぷん消化酵素、たん白消化酵素、脂肪消化酵素及び繊維素消化酵素など)、バル プロ酸ナトリウム、イブプロフェン、グァイフェネシン及び臭化ブチルスコポラミンなど が挙げられ、ゥイスカーを発生する薬物としてはイブプロフェン、無水カフェイン、ェテ ンザミド、イソプロピルアンチピリン及び L—メントールなどが挙げられる。これらの薬 物の配合量は、薬物の用途に応じて適宜調整することができるが、芯材に対して 0. 1〜99重量%が好ましぐより好ましくは 1〜85重量%である。 , Vitamin D, vitamin E, piotin, calcium pantothenate, nicotinamide, vitamin P and its derivatives), methylmethionine sulfo-um chloride, amino acids (such as aspartic acid and L-cysteine), adenosine Phosphate · Sodium salt, enzymes (starch digestive enzyme, protein digestive enzyme, fat digestive enzyme and fibrin digestive enzyme, etc.), sodium valproate, ibuprofen, guaifenesin and butyl scopolamine bromide Examples of drugs that generate ibuprofen, anhydrous caffeine, ethenamide, isopropylantipyrine, and L-menthol. These drugs The compounding amount of the product can be appropriately adjusted according to the use of the drug, but is preferably 0.1 to 99% by weight, more preferably 1 to 85% by weight based on the core material.
[0016] 本発明において、芯材に含有される薬物としては、例えば、以下の薬物が好ましく 挙げられる。 In the present invention, examples of the drug contained in the core material preferably include the following drugs.
〔ニンニク加工物〕  [Processed garlic]
ニン-ク加工物は、ユリ科ネギ属ニン-ク(Allium sativum 1.)の鱗茎をカ卩ェ処理して 得られるものである。加工処理の方法は特に制限されず、例えば、生ニンニクを乾燥 後粉末化したもの、生ニン-クを水蒸気蒸留、油、水、熱水又は水溶性有機溶媒等 で抽出したもの、生ニン-クを加熱等により処理したものを使用することができる。抽 出に用いる油としては、菜種油、ォリーブ油、大豆油等の食用植物油が挙げられ、水 溶性有機溶媒としては、エタノール、イソプロパノール等の低級アルコール;プロピレ ングリコール、ジエチレングリコール等のダリコール等が挙げられる。ニン-ク加工物 としては、乾燥後粉末化したもの、低級アルコールにより抽出したもの、加熱の加工 処理をしたものが特に好ましい。また、ニン-ク加工物は、市販品でもよい。例えば、 加工大蒜、ニン-ク抽出液、ニン-タエキス、乾燥ニン-ク等が好ましぐ特に加工大 蒜が好ましい。ここで、加工大蒜は、加熱処理ニン-クを低級アルコールで抽出して 得た抽出液を乾燥させたニンニク粉末であって、例えば、ォキソアミヂン (登録商標) (理研化学工業 (株)製)及びォキソレヂン (登録商標)(理研化学工業 (株)製)が巿 販されている。ニン-タエキスは、例えば、ニン-タエキス (アルプス薬品工業 (株))、 ニン-ク流エキス (日本粉末薬品 (株))等が市販されて ヽる。乾燥ニン-クは、例え ば、ガーリックパウダー、ローストガーリックパウダー EX (理研ィ匕学工業 (株)製)が巿 販されている。これらの市販されているニン-ク加工物の中では、ォキソアミヂン(登 録商標)(理研化学工業 (株)製)、ォキソレヂン (登録商標)(理研化学工業 (株)製) 、ニンニクエキス (アルプス薬品工業 (株))、ニンニク流エキス (日本粉末薬品 (株)) が好ましい。ニンニク加工物の配合量は、糖衣製剤の用途に応じて適宜調整するこ とが可能であるが、芯材に対して 2〜30重量%が好ましぐより好ましくは 5〜15重量 %である。  The processed garlic is obtained by subjecting bulbs of the allium sativum 1. The processing method is not particularly limited, for example, raw garlic dried and powdered, raw garlic extracted with steam distillation, oil, water, hot water or water-soluble organic solvent, raw garlic What was processed by heating etc. can be used. Examples of the oil used for extraction include edible vegetable oils such as rapeseed oil, olive oil, and soybean oil. Examples of the water-soluble organic solvent include lower alcohols such as ethanol and isopropanol; Daricol such as propylene glycol and diethylene glycol. . As the garlic processed product, those obtained by pulverization after drying, those extracted with a lower alcohol, and those processed by heating are particularly preferred. The processed garlic product may be a commercial product. For example, processed oak, garlic extract, nin-ta extract, dried garlic and the like are particularly preferred. Here, the processed oat is a garlic powder obtained by drying an extract obtained by extracting heat-treated garlic with a lower alcohol, for example, oxoamidin (registered trademark) (manufactured by Riken Chemical Industry Co., Ltd.) and Oxo Resin (registered trademark) (manufactured by Riken Chemical Industry Co., Ltd.) is on the market. Examples of the Ninta extract include Ninta extract (Alps Yakuhin Kogyo Co., Ltd.), Nin-ku extract (Nippon Powder Yakuhin Co., Ltd.) and the like. For example, garlic powder and roasted garlic powder EX (manufactured by Riken Igaku Kogyo Co., Ltd.) are commercially available. Among these commercially available garlic products, oxoamidin (registered trademark) (manufactured by Riken Chemical Industry Co., Ltd.), oxoresin (registered trademark) (manufactured by Riken Chemical Industry Co., Ltd.), garlic extract (alps) Yakuhin Kogyo Co., Ltd.) and garlic extract (Nippon Powder Chemical Co., Ltd.) are preferred. The amount of garlic processed product can be adjusted as appropriate according to the use of the sugar-coating preparation, but it is preferably 2 to 30% by weight, more preferably 5 to 15% by weight based on the core material. .
[0017] 〔メチルメチォニンスルホニゥムクロライド〕 メチルメチォニンスルホ -ゥムクロライド (MMSC)は、公知の製造方法に従って得る ことができる。また、市販品として、例えば、メチルメチォニンスルホ -ゥムクロライド( 米沢浜理薬品製、アルプス薬品工業製)等が市販されている。 MMSCの配合量は、 芯材に対して 1〜80重量%が好ましく、より好ましくは 10〜40重量%である。 [Methylmethionine sulfone chloride] Methylmethionine sulfo-um chloride (MMSC) can be obtained according to a known production method. Further, as a commercial product, for example, methylmethionine sulfo-um chloride (manufactured by Yonezawa Hamari Chemical Co., Ltd., manufactured by Alps Pharmaceutical Co., Ltd.) is commercially available. The blending amount of MMSC is preferably 1 to 80% by weight, more preferably 10 to 40% by weight with respect to the core material.
[0018] また、 MMSCを配合する芯材には、胃酸を中和する成分や胃酸の分泌を抑える成 分 (制酸成分)、胃の働きを高める成分 (健胃成分)、消化を補助する成分 (消化酵素 )、胃粘膜を修復する成分 (粘膜修復成分)等を、更に含有させることも好ましい。  [0018] In addition, the core material containing MMSC has a component that neutralizes gastric acid, a component that suppresses secretion of gastric acid (antacid component), a component that enhances stomach function (healthy stomach component), and assists digestion It is also preferable to further contain a component (digestive enzyme), a component that repairs the gastric mucosa (mucosal repair component), and the like.
[0019] 制酸成分としては、合成ヒドロタルサルト、炭酸水素ナトリウム、メタケイ酸アルミン酸 マグネシウム、水酸ィ匕アルミニウム ·炭酸水素ナトリウム共沈物、ロートエキス、水酸ィ匕 アルミニウム、炭酸水素ナトリウム、炭酸マグネシウム、沈降炭酸カルシウム、沈降炭 酸マグネシウム、ジヒドロキシアルミニウムァミノアセテート、水酸化マグネシウム、酸 ィ匕マグネシウム、乾燥水酸化アルミニウムゲル、ケィ酸アルミン酸マグネシウムビスマ ス、ケィ酸マグネシウム、合成ケィ酸アルミニウム、塩酸ラ-チジン、シメチジン、ファ モチジン、ニザチジン、ラフチジン、オメブラゾール、ランソプラゾール、パントプラゾ ール、ラベブラゾールナトリウム、レミノプラゾール、ェソメプラゾール、塩酸ピレンゼピ ン、プログルミド等が挙げられる。  [0019] As the antacid component, synthetic hydrotalsart, sodium hydrogen carbonate, magnesium aluminate metasilicate, sodium hydroxide-aluminum sodium carbonate coprecipitate, funnel extract, sodium hydroxide aluminum, sodium hydrogen carbonate, Magnesium carbonate, precipitated calcium carbonate, precipitated magnesium carbonate, dihydroxyaluminum aminoacetate, magnesium hydroxide, magnesium oxide, dried aluminum hydroxide gel, magnesium bismuth silicate, magnesium silicate, synthetic aluminum silicate, Latidine hydrochloride, cimetidine, famotidine, nizatidine, lafutidine, omebrazole, lansoprazole, pantoprazole, rabebrazole sodium, leminoprazole, esomeprazole, pirenzepine hydrochloride, proglumi And the like.
健胃成分としては、センブリ末、ホップエキス、ゲンチアナエキス、ウイキヨゥ末、ショ ゥキヨウ末、チヨウジ末、ァカメガシヮ末、ァセンャク末、ゥコン末、ゥバイ末、ゥャク末、 ォゥゴン末、ォゥバタ末、ォゥレン末、ガジュッ末、カツコゥ末、カンゾゥ末、キコク末、 キナ末、クジン末、ケィヒ末、ケッメイシ末、ゲンノショウコ末、コゥジン末、コゥボタ末、 ゴシュュ末、ゴバイシ末、コロンボ末、チンピ末、サンザシ末、サンショウ末、サンナ末 、シソシ末、シュタシャ末、ショウズク末、セィヒ末、セキショウコン末、ソウジュッ末、ソ ヨウ末、ダイォゥ末、チクセッニンジン末、トウヒ末、 -ガキ末、 -クズク末、ニンジン末 、ヒキォコシ末、ヒハツ末、ビヤクジュッ末、モッコゥ末、ャクチ末、ョウノくィヒ末、ハツ力 油、リンドウ末、リヨゥキヨウ末、ァニス実、アロエ、スィサイヨウ、ダイウイキヨウ、コンズラ ンゴ、加工大蒜、カラムス根、センタウリウム草、ホミカエキス、乾燥酵母、塩化カル- チン、グルタミン酸、塩ィ匕べタネコール、マレイン酸トリメブチン等が挙げられる。 消化酵素としては、ビォヂアスターゼ、リパーゼ、ウルソデォキシコール酸、含糖べ プシン、ジァスメン、セルラーゼ、セル口シン、タカヂアスターゼ、胆汁末、デヒドロコー ル、ニューラーゼ、パンクレアチン、ビオタミラーゼ、プロザィム、ポリパーゼ等が挙げ られる。 The components of healthy stomach include: assembly powder, hop extract, gentian extract, wikiyo powder, shokiyo powder, chiyouji powder, akamegashi powder powder, acenic powder powder, turmeric powder powder, ubai powder powder, wook powder powder, wogon powder powder End, Katsuko End, Kanzo End, Kikoku End, Kina End, Kuzin End, Keihi End, Kemi Mei End, Genno Shoko End, Koujin End, Kobota End, Goshu End, Gobai End, Colombo End, Chimpi End, Hawthorn End, Hawthorn End , Sanna powder, Soshishi powder, Stasha powder, Shozuk powder, Sehi powder powder, Sekishokon powder powder, Soujutsu powder powder, Soyo powder powder, Daio powder powder, Chikusennin powder powder, Spruce powder powder,-Gaki powder powder,-Kukuk powder powder, Carrot powder powder, Hikokoshi End, hihatsu end, biakujutsu end, mokkou end, yakchi end, yono kuhihi end, hat power , Gentian powder, ryokuki powder, varnished fruit, aloe, sweet potato, daiwi quill, tundurangia, processed potato, calamus root, centaulium grass, honey extract, dry yeast, carcin chloride, glutamic acid, salted betanechol, trimebutine maleate, etc. Is mentioned. Digestive enzymes include biodiastase, lipase, ursodeoxycholic acid, Examples include pussin, diasmen, cellulase, cell mouth sine, takadiastase, bile powder, dehydrochol, neurase, pancreatin, biotamirase, prozyme, and polypase.
粘膜修復成分としては、スクラルフアート、アルジォキサ、 L—グルタミン、ソファルコ ン、銅クロ口フィンナトリウム、銅クロ口フィンカリウム、塩酸セトラキサート、ゲファルナ ート、マレイン酸トリメブチン、ァズレンスルフォン酸ナトリウム等が挙げられる。  Mucosal repair ingredients include sucralfate, aldioxa, L-glutamine, sofalcone, copper black mouth fin sodium, copper black mouth fin potassium, cetraxate hydrochloride, gefarnate, trimebutine maleate, sodium azulensulphonate, etc. Can be mentioned.
[0020] 〔パルブロ酸ナトリウム〕 [0020] [Sodium parbromate]
バルプロ酸ナトリウムは、公知の製造方法に従って得ることができる(例えば、特開 昭 60— 156638号公報、特開昭 62— 106041号公報、特開昭 63— 122646号公 報、特開平 10— 130197号公報参照)。また、市販品として、例えば、バルプロ酸ナ トリウム(日本合成化学工業製、ァリババ製)等が市販されている。バルプロ酸ナトリウ ムの配合量は、芯材に対して 1〜80重量%が好ましぐより好ましくは 30〜60重量% である。  Sodium valproate can be obtained according to a known production method (for example, JP-A-60-156638, JP-A-62-160441, JP-A-63-122646, JP-A-10-130197). No. publication). As commercial products, for example, sodium valproate (manufactured by Nippon Synthetic Chemical Industry, manufactured by Alibaba) is commercially available. The blending amount of sodium valproate is preferably 1 to 80% by weight, more preferably 30 to 60% by weight based on the core material.
[0021] また芯材には上記の薬物のほかに、経口投与可能な各種任意成分を所望に応じ て配合する事が可能である。そのような経口投与可能な各種任意添加物として、例え ば、賦形剤、結合剤、崩壊剤、滑沢剤等が挙げられる。  [0021] In addition to the above drugs, various optional components that can be administered orally can be blended in the core material as desired. Examples of such various optional additives that can be administered orally include excipients, binders, disintegrants, lubricants, and the like.
賦形剤としては、乳糖、結晶セルロース、蔗糖、マン-トール、軽質無水ケィ酸、リン 酸水素カルシウム及びトウモロコシデンプン等が挙げられる。  Examples of excipients include lactose, crystalline cellulose, sucrose, mannitol, light anhydrous carboxylic acid, calcium hydrogen phosphate, and corn starch.
結合剤としては、メチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピ ルメチルセルロース、ゼラチン、ポリビュルピロリドン及びプルラン等が挙げられる。 崩壊剤としては、カルメロースカルシウム、低置換度ヒドロキシプロピルセルロース、 クロスポピドン及びクロスカルメロースナトリウム等が挙げられる。  Examples of the binder include methyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, gelatin, polybutylpyrrolidone and pullulan. Examples of the disintegrant include carmellose calcium, low-substituted hydroxypropyl cellulose, crospovidone, and croscarmellose sodium.
滑沢剤としては、ステアリン酸マグネシウム、ステアリン酸カルシウム及びタルク等が 挙げられる。  Examples of the lubricant include magnesium stearate, calcium stearate and talc.
[0022] 本発明の糖衣製剤に用いる芯材は、薬物及びその他任意成分を用いて常法により 製造することができる。  [0022] The core material used in the sugar-coated preparation of the present invention can be produced by a conventional method using a drug and other optional components.
例えば、素錠の場合は、配合する薬物及びその他任意添加物を造粒した後、造粒 物を打錠する方法、あるいは配合する薬物及びその他任意添加物を造粒した後、こ れらを整粒機で整粒して粉体とし、更に必要に応じてその粉体にその他任意添加物 を添加、混合した粉体とした後、これらの粉体を打錠する方法、または、直接に配合 する薬物及びその他任意添加物を混合して打錠機にて打錠する方法などが挙げら れる。 For example, in the case of an uncoated tablet, after granulating the drug to be blended and other optional additives, a method of tableting the granulated product, or after granulating the drug to be blended and other optional additives, These are sized with a sizing machine to form powder, and if necessary, other optional additives are added to the powder and mixed to obtain powder, or these powders are tableted, or Examples thereof include a method in which a directly blended drug and other optional additives are mixed and tableted with a tableting machine.
ここで造粒としては、乾式造粒法と湿式造粒法が挙げられ、乾式造粒法とは、水、 エタノール、イソプロパノール及びこれらの混合液などの液体を用いることなく粉体を 乾式造粒機等により圧縮成形し、板状の固形物を製した後これらを破壊し、粒状物を 製する方法である。  Here, examples of the granulation include a dry granulation method and a wet granulation method. In the dry granulation method, a powder is dry granulated without using a liquid such as water, ethanol, isopropanol, or a mixture thereof. This is a method of producing a granular material by compression molding with a machine or the like to produce a plate-like solid material, and then breaking these.
また湿式造粒法とは、高速攪拌造粒機、練合造粒機、流動層造粒機、転動流動造 粒機等を用いて結合液を粉体に添加し、粒子を形成した後に乾燥を実施する方法 で、結合液の種類は特に限定されないが、水、エタノール、イソプロパノール及びこ れらの混合液を用いることができる。  The wet granulation method is a method in which a binding liquid is added to a powder by using a high speed stirring granulator, a kneading granulator, a fluidized bed granulator, a rolling fluid granulator, etc., to form particles. In the method for carrying out the drying, the type of the binding solution is not particularly limited, but water, ethanol, isopropanol and a mixture thereof can be used.
[0023] 次に芯顆粒の場合は、配合する薬物及びその他任意添加物を乾式造粒法にて顆 粒化する方法、湿式造粒法または湿式造粒法と押出し造粒法とを組み合わせて顆 粒ィ匕する方法などが挙げられる。  [0023] Next, in the case of a core granule, the drug to be blended and other optional additives are granulated by a dry granulation method, a wet granulation method or a wet granulation method and an extrusion granulation method in combination. For example, the method of condylar grain.
本発明の糖衣製剤に含まれる上記芯材を被覆する糖衣層の少なくとも 1つは、糖 及びアクリル酸ェチル 'メタクリル酸メチルコポリマー 0. 01〜10重量%を含むことを 特徴とする。  At least one of the sugar coating layers covering the core material contained in the sugar coating preparation of the present invention is characterized in that it contains sugar and 0.01 to 10% by weight of ethyl acrylate / methyl methacrylate copolymer.
[0024] また、本発明の糖衣製剤は、本発明の糖衣液を用いて形成された 1又は複数の糖 衣層以外にも他のコーティング液で形成された 1又は複数の被覆層を有していてもよ い。なお、本明細書では、本発明の糖衣液により形成される層を「糖衣層」、該糖衣 層及び本発明の糖衣液以外のコ一ティング液で形成された層を合わせて「被覆層」 と記載することがある。  [0024] In addition, the sugar-coated preparation of the present invention has one or more coating layers formed of another coating liquid in addition to the one or more sugar-coated layers formed of the sugar coating liquid of the present invention. May be. In the present specification, the layer formed from the sugar coating liquid of the present invention is referred to as “sugar coating layer”, and the layer formed from the sugar coating layer and the coating liquid other than the sugar coating liquid of the present invention is referred to as “coating layer”. May be described.
被覆層は、その機能により防水層(protective coating)、下掛層(subcoating)、中掛 層(smoothing)、上掛層(coloring)及び艷出層(polishing)等の複数の層などに分け ることができる。これら各層の被覆層全体に対する割合は、通常、防水層が 0〜20% 、下掛層が 15〜100%、中掛層が 0〜50%、上掛層が 0〜50%及び艷出層が 0〜1 0%である。防水層は糖衣工程中における芯材への水分移行を抑制するために施す ものである。また、下掛層は糖衣錠の形を整えるために施すものであり、糖衣錠の外 観、強度の優劣はこの下掛層の良し悪しに影響される。また、中掛層は糖衣錠の表 面を平滑にするため、上掛層は着色して糖衣錠の識別性や商品価値を高めるため、 艷出層は糖衣錠に艷を与えるために施すものである。本発明の糖衣製剤は、必ずし も上記機能を有する全ての被覆層を有している必要はないが、下掛層の機能を有す る被覆層を含むことが好ましぐ本発明の糖衣液を用いて形成した糖衣層は、下掛層 の機能を有する被覆層として好適に用いることができる。 The covering layer is divided into a plurality of layers such as a protective layer, a subcoating layer, a smoothing layer, a coloring layer and a polishing layer according to the function. be able to. The ratio of each of these layers to the entire coating layer is usually 0-20% for the waterproof layer, 15-100% for the undercoat layer, 0-50% for the midcoat layer, 0-50% for the overcoat layer, and the leach layer Is 0 to 10%. A waterproof layer is applied to suppress moisture transfer to the core during the sugar coating process Is. The undercoat layer is applied to shape the sugar-coated tablet, and the appearance and strength of the sugar-coated tablet are affected by the quality of the undercoat layer. In addition, the intermediate layer is applied to smoothen the surface of the sugar-coated tablet, and the upper layer is colored to enhance the distinguishability and commercial value of the sugar-coated tablet. The sugar-coated preparation of the present invention does not necessarily have to have all the coating layers having the above functions, but it is preferable to include a coating layer having the function of the undercoat layer. The sugar-coating layer formed using the liquid can be suitably used as a coating layer having the function of an undercoat layer.
[0025] 更に、本発明の糖衣製剤には、目的に応じて上記被覆層とは別に放出制御層も被 覆することができる。放出制御層は芯材に含む薬物の溶出を制御する機能を付与す るために施すものであり、 1又は複数の層であってもよい。放出制御層は、芯材に直 接被覆するか、あるいは上記の防水層、下掛層、中掛層、上掛層及び艷出層のいず れの間に施すこともできるが、通常は芯材に被覆するのが好ましい。放出制御層を被 覆する場合は、糖衣製剤 1重量部に対し 1〜10重量%が好ましぐより好ましくは 2〜 8重量%である。また放出制御層を施す方法や用いる成分は、常法のものが使用で きる。  [0025] Furthermore, the sugar-coated preparation of the present invention can be covered with a release controlling layer in addition to the coating layer according to the purpose. The release control layer is applied to give a function of controlling the dissolution of the drug contained in the core material, and may be one or a plurality of layers. The release control layer can be applied directly to the core material, or it can be applied between any of the waterproof layer, undercoat layer, intermediate coat layer, overcoat layer, and leach layer. It is preferable to coat the core material. When covering the controlled release layer, 1 to 10% by weight is more preferable with respect to 1 part by weight of the sugar-coating preparation, more preferably 2 to 8% by weight. In addition, conventional methods can be used as the method for applying the release controlling layer and the components used.
[0026] 本発明の糖衣製剤における本発明の糖衣液を用いて形成した糖衣層の重量は、 芯材の重量に対して 5〜60重量%が好ましぐより好ましくは 10〜50重量%である。 糖衣層の重量が 60重量%を超えるとコーティング工程の時間が長くなり、仕込んだ 芯材の質量に対して出来上がりの糖衣製剤の質量が大きくなるため別途コーティン グ装置が必要になるといった問題が生じる。また 5重量%未満だと充分な被覆層の硬 度が得られず、また、被覆層が薄いため、環境湿度から素錠または芯顆粒などの内 容物を保護することが出来ないなどの問題を生じることがある。  [0026] The weight of the sugar coating layer formed using the sugar coating liquid of the present invention in the sugar coating preparation of the present invention is preferably 5 to 60% by weight, more preferably 10 to 50% by weight, based on the weight of the core material. is there. If the weight of the sugar-coating layer exceeds 60% by weight, the coating process takes longer time, and the mass of the finished sugar-coating preparation increases with respect to the mass of the core material charged, resulting in the need for a separate coating device. . If the amount is less than 5% by weight, sufficient coating layer hardness cannot be obtained, and the coating layer is too thin to protect the contents such as uncoated tablets or core granules from environmental humidity. May occur.
[0027] 本発明の糖衣製剤における吸湿率は、温湿度 25°C -85%における 24時間後の 条件下では、好ましくは 1. 0%以下、さらに好ましくは 0. 5%以下であり、温湿度 40 °C— 75%における 30日後の条件下では、好ましくは 4. 0%以下、さらに好ましくは 3 . 0%以下である。また、硬度や崩壊度については、本発明の糖衣製剤の使用目的 や芯材に含まれる薬物に応じて適宜調整が可能である。  [0027] The moisture absorption rate in the sugar-coated preparation of the present invention is preferably 1.0% or less, more preferably 0.5% or less under the conditions after 24 hours at a temperature and humidity of 25 ° C -85%. Under the condition after 30 days at a humidity of 40 ° C.-75%, it is preferably 4.0% or less, more preferably 3.0% or less. In addition, the hardness and the degree of disintegration can be appropriately adjusted according to the intended use of the sugar-coated preparation of the present invention and the drug contained in the core material.
本発明の糖衣製剤の芯材がニン-ク加工物を含有する場合は、糖衣製剤の硬度 は好ましくは 100N以上、さらに好ましくは 110N以上である。また、崩壊度は 25分以 内が好ましい。 When the core material of the sugar-coated preparation of the present invention contains processed garlic, the hardness of the sugar-coated preparation Is preferably 100N or more, more preferably 110N or more. The degree of disintegration is preferably within 25 minutes.
本発明の糖衣製剤の芯材カ SMMSCを含有する場合は、糖衣製剤の硬度は好ましく は 65N以上、さらに好ましくは 70N以上である。また崩壊度は、 15分以内が好ましい 本発明の糖衣製剤の芯材がパルプ口酸ナトリウムを含有する場合は、糖衣製剤の 硬度は好ましくは 65N以上、さらに好ましくは 70N以上である。  In the case where the core material SMMSC of the sugar-coated preparation of the present invention is contained, the hardness of the sugar-coated preparation is preferably 65 N or more, more preferably 70 N or more. The disintegration degree is preferably within 15 minutes. When the core material of the sugar-coating preparation of the present invention contains sodium pulp oleate, the hardness of the sugar-coating preparation is preferably 65 N or more, more preferably 70 N or more.
[0028] 本発明の糖衣製剤は、本発明の糖衣液の噴霧工程、及び乾燥工程を同時に行う 連続コーティング法により糖衣層を形成して製造することができる。すなわち、本発明 の糖衣液を薬物を含む芯材に噴霧しながら、乾燥を行うことにより、芯材を覆う糖衣 液中の溶剤を飛ばして糖衣層を形成することができる。また、用いる芯材 (素錠ある いは芯顆粒)により、糖衣錠や糖衣顆粒の剤形とすることができる。  [0028] The sugar-coated preparation of the present invention can be produced by forming a sugar-coated layer by a continuous coating method in which the step of spraying the sugar-coating liquid of the present invention and the drying step are simultaneously performed. That is, by spraying the sugar-coating liquid of the present invention on the core material containing the drug, drying is carried out, so that the solvent in the sugar-coating liquid covering the core material can be removed to form a sugar-coating layer. Also, depending on the core material used (plain tablet or core granule), a sugar-coated tablet or sugar-coated granule can be prepared.
[0029] 糖衣錠を製造する場合には、連続的に回転するコーティング装置内に薬物を含む 素錠又はこれに防水層等を施したプロテクト掛錠を投入し、装置内で回転する素錠 又はプロテクト掛錠に対して糖衣液の噴霧と乾燥を同時に行うことにより、芯材を被 覆する糖衣層を形成することができる。連続コーティング法に用いる装置としては、例 えばノヽイコーター(フロイント産業)、アクアコーター(フロイント産業)、パゥレツタコー ター(パゥレック)、ドリアコ一ター(パゥレック)等が挙げられる。  [0029] When a sugar-coated tablet is manufactured, an uncoated tablet containing a drug or a protective lock with a waterproof layer or the like is placed in a continuously rotating coating apparatus, and the uncoated tablet or protect rotating within the apparatus By simultaneously spraying and drying the sugar coating liquid on the hanging lock, a sugar coating layer covering the core material can be formed. Examples of equipment used for the continuous coating method include a Neucoater (Freund Sangyo), Aqua Coater (Freund Sangyo), Palleta Coater (Paulek), and Doria Coater (Paulek).
噴霧する糖衣液の液滴径は、 0. 1〜1, 000 mとすることが好ましぐ噴霧量は、 芯材の大きさや量に応じて芯材の表面全体に行き渡るよう調節すればよい。また、糖 衣液の温度は 10〜80°Cとすることが好ましい。給気温度及び風量については、製品 温度が 10〜60°Cになるように調節することが好まし!/、。  The droplet size of the sugar coating liquid to be sprayed is preferably 0.1 to 1,000 m. The spray amount is preferably adjusted to spread over the entire surface of the core material according to the size and amount of the core material. . The temperature of the sugar coating liquid is preferably 10 to 80 ° C. It is preferable to adjust the supply air temperature and air volume so that the product temperature is 10-60 ° C! /.
[0030] 糖衣顆粒を製造する場合には、流動層コーティング機を使用して行なうことが好ま しぐ特に底部に回転盤を有する転動流動層コーティング機を使用することが望まし い。例えば、マルチプレックス(パゥレック)、ダラ-ュレックス(フロイント産業)、スパイ ラフロー(フロイント産業)、ァグロマスタ(ホソカワミクロン)、ニューマルメライザ一(不 ニパゥダル)等が挙げられる。  [0030] When producing sugar-coated granules, it is preferable to use a fluidized bed coating machine, and it is particularly desirable to use a rolling fluidized bed coating machine having a rotating disk at the bottom. For example, multiplex (Paurek), Darreux (Freund industry), Spiraflow (Freund industry), Agromaster (Hosokawamicron), and Numeralizer (non-nipadal).
連続的に本体底面部が回転するコーティング装置内に薬物を含む顆粒又はこれに 防水層等を施したプロテ外掛顆粒を投入し、装置内で流動及び回転する顆粒又は プロテクト掛顆粒に対して糖衣液の噴霧と乾燥を同時に行うことにより、芯材を被覆 する糖衣層を形成することができる。 Granules containing drugs in a coating device whose bottom surface of the main body rotates continuously, or Protease-coated granules with a waterproof layer, etc. are introduced, and a sugar coating layer covering the core material is formed by simultaneously spraying and drying the sugar coating liquid on the granules that flow and rotate in the apparatus or the protection-coated granules. be able to.
噴霧する糖衣液の液滴径は、 0. 1〜: LOO mとすることが好ましぐ噴霧量は、芯 材の大きさや量に応じて芯材の表面全体に行き渡るよう調節すればよい。また、糖衣 液の温度は 10〜80°Cとすることが好ましい。給気温度及び風量については、製品温 度が 10〜50°Cになるように調節することが好ま 、。  The droplet size of the sugar-coating liquid to be sprayed should be adjusted to 0.1 to LOO m so that the spray amount spreads over the entire surface of the core material according to the size and amount of the core material. The temperature of the sugar coating liquid is preferably 10 to 80 ° C. It is preferable to adjust the supply air temperature and air volume so that the product temperature is 10-50 ° C.
[0031] また、本発明の糖衣液以外のコーティング液による被覆層の形成は、糖衣製剤の 製造に一般的に用いられる方法で行うことができる。この際用いるコーティング装置も コーティング液の種類などにより適宜選択して使用することができ、特に制限されな い。また、コーティング液を噴霧する場合の液滴や噴霧量についても糖衣液の噴霧と 同様に調節することができる。 [0031] The formation of the coating layer with a coating solution other than the sugar coating solution of the present invention can be carried out by a method generally used in the manufacture of sugar coating preparations. The coating apparatus used at this time can be appropriately selected and used depending on the type of the coating solution, and is not particularly limited. In addition, the droplets and spray amount when spraying the coating liquid can be adjusted in the same manner as the spraying of the sugar coating liquid.
このようにして得られる本発明の糖衣製剤は、従来の製剤と比べて糖衣層が薄ぐ 十分な硬度を有し、かつ低吸湿性、防臭性及び崩壊性にも優れている。  The sugar-coated preparation of the present invention thus obtained has a sufficient hardness that the sugar-coated layer is thin compared to conventional preparations, and is excellent in low moisture absorption, deodorization and disintegration.
実施例  Example
[0032] 以下に、実施例を用いて本発明を具体的に説明する。  Hereinafter, the present invention will be specifically described with reference to examples.
<製造例 1 >  <Production example 1>
乳糖 3000g、ヒドロキシプロピルセルロース(HPC— L :日本曹達) 150g、トウモロコ シデンプン 1200g、結晶セルロース(セォラス PH— 101 :旭化成) lOOOgを高速攪 拌造粒機 (VG— 25 :バウレック)に投入し、精製水を加えることで造粒物を調製した。 これを流動層乾燥機 (FLO— 5B :フロイント産業)にて乾燥をし、その後整粒機 (パヮ 一ミル、昭和化学機械)にて乾燥物を整粒した。  Lactose 3000g, hydroxypropylcellulose (HPC—L: Nippon Soda) 150g, corn starch 1200g, crystalline cellulose (Ceras PH—101: Asahi Kasei) lOOOg was put into a high-speed agitation granulator (VG—25: Baurek) and purified. A granulated product was prepared by adding water. This was dried with a fluidized bed dryer (FLO-5B: Freund Sangyo), and then the dried product was sized with a sizing machine (Pair Mill, Showa Chemical Machinery).
得られた整粒物 5350gにステアリン酸マグネシウム 50gを混合し、これをロータリー 式打錠機 (HP— AP18— SS :畑鐡ェ所)にて、 1錠当たり 270mgの素錠を製造した 得られた素錠 5400gに、ヒドロキシプロピルメチルセルロース 2910 (TC - 5R:信越 化学工業) 100g及び精製水 900gからなるコーティング液を用い、コーティング機(ド リアコーター DRC— 650、ノ ゥレック)にて素錠に防水層を施し、 1錠当たり 275mg のプロテクト掛錠を製造した。 50350 g of magnesium stearate was mixed with 5350 g of the obtained granulated product, and 270 mg of uncoated tablets were produced per tablet using a rotary tableting machine (HP-AP18-SS: Hata Kyosho). Using a coating solution consisting of 100 g of hydroxypropylmethylcellulose 2910 (TC-5R: Shin-Etsu Chemical Co., Ltd.) and 900 g of purified water on 5400 g of uncoated tablet, a waterproof layer is applied to the uncoated tablet using a coating machine (Drier Coater DRC-650, Norrec). 275mg per tablet Protective lock was manufactured.
[0033] <実施例 1 >  <Example 1>
製造例 1で得たプロテクト掛錠 5500gに、グラニュー糖 1180g、タルク 400g、沈降 炭酸カルシウム 400g、アクリル酸ェチル 'メタクリル酸メチルコポリマー 30%分散液( オイドラギット NE30D:樋口商会) 66. 7g及び精製水 2000gからなる懸濁した糖衣 液を用い、コーティング機(ドリアコ一ター DRC— 650、ノ ゥレック)にて糖衣液を噴 霧しながら乾燥を行い、 1錠当たり 375mgの糖衣錠を得た。なお、コーティング作業 に費やした時間は 2時間であった。  Protected tablet 5500g obtained in Production Example 1, Granulated sugar 1180g, Talc 400g, Precipitated calcium carbonate 400g, Ethyl acrylate 'Methyl methacrylate copolymer 30% dispersion (Eudragit NE30D: Higuchi Shokai) 66.7g and purified water 2000g The suspension was coated with a sugar coating liquid (Driacoater DRC-650, Norrec) and dried while spraying the sugar coating liquid to obtain 375 mg sugar coated tablets per tablet. The time spent on the coating work was 2 hours.
[0034] <実施例 2>  <Example 2>
製造例 1で得たプロテクト掛錠 5500gに、グラニュー糖 1160g、タルク 400g、沈降 炭酸カルシウム 400g、アクリル酸ェチル 'メタクリル酸メチルコポリマー 30%分散液( オイドラギット NE30D :樋口商会) 133. 3g及び精製水 2000gからなる懸濁した糖衣 液を用い、コーティング機(ドリアコ一ター DRC— 650、バウック)にて糖衣液を噴霧 しながら乾燥を行い、 1錠当たり 375mgの糖衣錠を得た。なお、コーティング作業に 費やした時間は 2時間であった。  Protected tablet 5500g obtained in Production Example 1, Granulated sugar 1160g, Talc 400g, Precipitated calcium carbonate 400g, Ethyl acrylate 'Methyl methacrylate copolymer 30% dispersion (Eudragit NE30D: Higuchi Shokai) 133. 3g and purified water 2000g The suspension was coated with a sugar coating liquid (Driacoater DRC-650, Bauch) and dried while spraying the sugar coating liquid to obtain 375 mg sugar coated tablets per tablet. The time spent for the coating work was 2 hours.
[0035] <実施例 3 >  <Example 3>
製造例 1で得たプロテクト掛錠 5500gに、グラニュー糖 1120g、タルク 400g、沈降 炭酸カルシウム 400g、アクリル酸ェチル 'メタクリル酸メチルコポリマー 30%分散液( オイドラギット NE30D :樋口商会) 266. 7g及び精製水 2000gからなる懸濁した糖衣 液を用い、コーティング機(ドリアコ一ター DRC— 650、ノ ゥレック)にて糖衣液を噴 霧しながら乾燥を行い、 1錠当たり 375mgの糖衣錠を得た。なお、コーティング作業 に費やした時間は 2時間であった。  Protected tablet 5500g obtained in Production Example 1, Granulated sugar 1120g, Talc 400g, Precipitated calcium carbonate 400g, Ethyl acrylate 'Methyl methacrylate copolymer 30% dispersion (Eudragit NE30D: Higuchi Shokai) 266. 7g and purified water 2000g The suspension was coated with a sugar coating liquid (Driacoater DRC-650, Norrec) and dried while spraying the sugar coating liquid to obtain 375 mg sugar coated tablets per tablet. The time spent on the coating work was 2 hours.
[0036] <比較例 1 >  <Comparative Example 1>
製造例 1で得たプロテクト掛錠 5500gに、グラニュー糖 1160g、タルク 400g、沈降 炭酸カルシウム 400g、ヒドロキシプロピルメチルセルロース 2910 (TC— 5R:信越化 学工業) 40g及び精製水 2000gからなる懸濁した糖衣液を用い、コーティング機(ドリ アコ一ター DRC— 650、ノ ゥレック)にて糖衣液を噴霧しながら乾燥を行い、 1錠当 たり 375mgの糖衣錠を得た。なお、コーティング作業に費やした時間は 2時間であつ た。 Suspended dragee solution consisting of 5160 g of protected latch obtained in Production Example 1, 1160 g of granulated sugar, 400 g of talc, 400 g of precipitated calcium carbonate, 40 g of hydroxypropylmethylcellulose 2910 (TC-5R: Shin-Etsu Chemical Co., Ltd.) and 2000 g of purified water Using a coating machine (Drycoater DRC-650, Norrec), the sugar coating solution was sprayed and dried to obtain 375 mg sugar coated tablets per tablet. The time spent on coating is 2 hours. It was.
[0037] <比較例 2>  [0037] <Comparative Example 2>
製造例 1で得たプロテクト掛錠 5500gに、グラニュー糖 1924g、タルク 542g、沈降 炭酸カノレシゥム 818g、アラビアゴム 64g、ゼラチン 30g、ポリオキシエチレン(105)ポ リオキシプロピレン(5)グリコール(PEP— 101 :フロイント産業) 22g及び精製水 120 Ogからなる懸濁した糖衣液を用い、コーティング機(ドリアコ一ター DRC— 650、パ ゥレック)にて糖衣液の噴霧、蒸らし、乾燥を別々に行う従来の糖衣コーティング方法 により、 1錠当たり 445mgの糖衣錠を得た。なお、コーティング作業に費やした時間 は 6. 5時間であった。  Protected tablet 5500g obtained in Production Example 1 was added to granulated sugar 1924g, talc 542g, precipitated canoresium carbonate 818g, gum arabic 64g, gelatin 30g, polyoxyethylene (105) polyoxypropylene (5) glycol (PEP-101: Freund Sangyo Co., Ltd. A conventional sugar coating that uses a sugar coating liquid suspended in 22 g and 120 Og of purified water, and sprays, steams and drys the sugar coating liquid separately in a coating machine (Driacoater DRC-650, Paurek). According to the method, 445 mg of sugar-coated tablets were obtained per tablet. The time spent for the coating work was 6.5 hours.
[0038] <製造例 2> [0038] <Production example 2>
ニン-タカ卩ェ物 500g (ォキソアミヂン、理研ィ匕学工業 (株)製)、乳糖 2500g、ヒドロ キシプロピルセルロース(HPC— L :日本曹達) 150g、トウモロコシデンプン 1200g、 結晶セルロース (セォラス PH— 101:旭化成) lOOOgを高速攪拌造粒機 (VG- 25: ノ ゥレック)に投入し、精製水を加えることで造粒物を調製した。これを流動層乾燥機 (FLO— 5B :フロイント産業)にて乾燥をし、その後整粒機 (パワーミル、昭和化学機 械)にて乾燥物を整粒した。  Nin-Takae 500g (Oxoamidin, Riken Igaku Kogyo Co., Ltd.), Lactose 2500g, Hydroxypropylcellulose (HPC—L: Nippon Soda) 150g, Corn starch 1200g, Crystalline cellulose (Chorus PH—101: Asahi Kasei) lOOOg was put into a high-speed agitation granulator (VG-25: Norec) and purified water was added to prepare a granulated product. This was dried with a fluidized bed dryer (FLO-5B: Freund Sangyo), and then the dried product was sized with a granulator (Power Mill, Showa Chemical Machinery).
得られた整粒物 5350gにステアリン酸マグネシウム 50gを混合し、これをロータリー 式打錠機 (HP— AP18— SS :畑鐡ェ所)にて、 1錠当たり 270mgの素錠を製造した 得られた素錠 5400gに、ヒドロキシプロピルメチルセルロース 2910 (TC - 5R:信越 化学工業) 100g及び精製水 900gからなるコーティング液を用い、コーティング機(ド リアコーター DRC— 650、ノ ゥレック)にて素錠に防水層を施し、 1錠当たり 275mg のプロテクト掛錠を製造した。  50350 g of magnesium stearate was mixed with 5350 g of the obtained granulated product, and 270 mg of uncoated tablets were produced per tablet using a rotary tableting machine (HP-AP18-SS: Hata Kyosho). Using a coating solution consisting of 100 g of hydroxypropylmethylcellulose 2910 (TC-5R: Shin-Etsu Chemical Co., Ltd.) and 900 g of purified water on 5400 g of uncoated tablet, a waterproof layer is applied to the uncoated tablet using a coating machine (Drier Coater DRC-650, Norrec). Protected locks of 275 mg per tablet were produced.
[0039] <実施例 4>  <Example 4>
製造例 2で得たプロテクト掛錠 5500gに、グラニュー糖 1180g、タルク 400g、沈降 炭酸カルシウム 400g、アクリル酸ェチル 'メタクリル酸メチルコポリマー 30%分散液( オイドラギット NE30D:樋口商会) 66. 7g及び精製水 2000gからなる懸濁した糖衣 液を用い、コーティング機(ドリアコ一ター DRC— 650、ノ ゥレック)にて糖衣液を噴 霧しながら乾燥を行い、 1錠当たり 375mgの糖衣錠を得た。なお、コーティング作業 に費やした時間は 2時間であった。 Protected tablet 5500g obtained in Production Example 2, granulated sugar 1180g, talc 400g, precipitated calcium carbonate 400g, ethyl acrylate 'methyl methacrylate copolymer 30% dispersion (Eudragit NE30D: Higuchi Shokai) 66.7g and purified water 2000g The sugar coating liquid is sprayed with a coating machine (Driacoater DRC-650, Norec) using the suspended sugar coating liquid consisting of Drying was carried out while fogging to obtain 375 mg sugar-coated tablets per tablet. The time spent on the coating work was 2 hours.
[0040] <実施例 5 >  [0040] <Example 5>
製造例 2で得たプロテクト掛錠 5500gに、グラニュー糖 1160g、タルク 400g、沈降 炭酸カルシウム 400g、アクリル酸ェチル 'メタクリル酸メチルコポリマー 30%分散液( オイドラギット NE30D :樋口商会) 133. 3g及び精製水 2000gからなる懸濁した糖衣 液を用い、コーティング機(ドリアコ一ター DRC— 650、ノ ゥレック)にて糖衣液を噴 霧しながら乾燥を行い、 1錠当たり 375mgの糖衣錠を得た。なお、コーティング作業 に費やした時間は 2時間であった。  Protected tablet 5500 g obtained in Production Example 2, granulated sugar 1160 g, talc 400 g, precipitated calcium carbonate 400 g, ethyl acrylate “methyl methacrylate copolymer 30% dispersion (Eudragit NE30D: Higuchi Shokai) 133.3 g and purified water 2000 g The suspension was coated with a sugar coating liquid (Driacoater DRC-650, Norrec) and dried while spraying the sugar coating liquid to obtain 375 mg sugar coated tablets per tablet. The time spent on the coating work was 2 hours.
[0041] <実施例 6 >  [0041] <Example 6>
製造例 2で得たプロテクト掛錠 5500gに、グラニュー糖 1120g、タルク 400g、沈降 炭酸カルシウム 400g、アクリル酸ェチル 'メタクリル酸メチルコポリマー 30%分散液( オイドラギット NE30D :樋口商会) 266. 7g及び精製水 2000gからなる懸濁した糖衣 液を用い、コーティング機(ドリアコ一ター DRC— 650、ノ ゥレック)にて糖衣液を噴 霧しながら乾燥を行い、 1錠当たり 375mgの糖衣錠を得た。なお、コーティング作業 に費やした時間は 2時間であった。  Protected tablet 5500g obtained in Production Example 2, Granulated sugar 1120g, Talc 400g, Precipitated calcium carbonate 400g, Ethyl acrylate 'Methyl methacrylate copolymer 30% dispersion (Eudragit NE30D: Higuchi Shokai) 266.7g and purified water 2000g The suspension was coated with a sugar coating liquid (Driacoater DRC-650, Norrec) and dried while spraying the sugar coating liquid to obtain 375 mg sugar coated tablets per tablet. The time spent on the coating work was 2 hours.
[0042] <比較例 3 >  [0042] <Comparative Example 3>
製造例 2で得たプロテクト掛錠 5500gに、グラニュー糖 1160g、タルク 400g、沈降 炭酸カルシウム 400g、ヒドロキシプロピルメチルセルロース 2910 (TC— 5R:信越化 学工業) 40g及び精製水 2000gからなる懸濁した糖衣液を用い、コーティング機(ドリ アコ一ター DRC— 650、ノ ゥレック)にて糖衣液を噴霧しながら乾燥を行い、 1錠当 たり 375mgの糖衣錠を得た。なお、コーティング作業に費やした時間は 2時間であつ た。  Suspended sugar-coating liquid consisting of 1160 g of granulated sugar, 400 g of talc, 400 g of precipitated calcium carbonate, 40 g of hydroxypropylmethylcellulose 2910 (TC-5R: Shin-Etsu Chemical Co., Ltd.) and 2000 g of purified water Using a coating machine (Drycoater DRC-650, Norrec), the sugar coating solution was sprayed and dried to obtain 375 mg sugar coated tablets per tablet. The time spent on the coating work was 2 hours.
[0043] <比較例 4>  <Comparative Example 4>
製造例 2で得たプロテクト掛錠 5500gに、グラニュー糖 1924g、タルク 542g、沈降 炭酸カノレシゥム 818g、アラビアゴム 64g、ゼラチン 30g、ポリオキシエチレン(105)ポ リオキシプロピレン(5)グリコール(PEP— 101 :フロイント産業) 22g及び精製水 120 Ogからなる懸濁した糖衣液を用い、コーティング機(ドリアコ一ター DRC— 650、ノ ゥレック)にて糖衣液の噴霧、蒸らし、乾燥を別々に行う従来の糖衣コーティング方法 により、 1錠当たり 445mgの糖衣錠を得た。なお、コーティング作業に費やした時間 は 6. 5時間であった。 Protected tablet 5500g obtained in Production Example 2, granulated sugar 1924g, talc 542g, precipitated canoresium carbonate 818g, gum arabic 64g, gelatin 30g, polyoxyethylene (105) polyoxypropylene (5) glycol (PEP-101: (Freund Sangyo Co., Ltd.) A coating machine (Driacoater DRC-650 The sugar coating liquid was sprayed, steamed, and dried separately in Ulek), and 445 mg of sugar-coated tablets were obtained per tablet. The time spent for the coating work was 6.5 hours.
[0044] <製造例 3 > [0044] <Production Example 3>
メチルメチォニンスルホ -ゥムクロライド lOOOg (メチルメチォ-ンスルホ -ゥムクロラ イド、米沢浜理薬品)、乳糖 600g、ポリビュルピロリドン (コリドン 30 : BASFジャパン) 300g、トウモロコシデンプン 1550g、カルメロースカルシウム(ECG— 505 :五徳薬 品) 500gを高速攪拌造粒機 (VG— 25 :パゥレック)に投入し、エタノールをカ卩えるこ とで造粒物を調製した。これを流動層乾燥機 (FLO— 5B :フロイント産業)にて乾燥 をし、その後整粒機 (パワーミル、昭和化学機械)にて乾燥物を整粒した。  Methylmethioninesulfo-umchloride lOOOg (Methylmethiononesulfo-umchloride, Yonezawa Hamariyaku), lactose 600g, polybylpyrrolidone (Kollidon 30: BASF Japan) 300g, corn starch 1550g, carmellose calcium (ECG- 505: Gotoku (Pharmaceutical) 500g was put into a high-speed agitation granulator (VG-25: Paurek), and the granulated product was prepared by covering with ethanol. This was dried with a fluidized bed dryer (FLO-5B: Freund Sangyo), and then dried with a granulator (Power Mill, Showa Chemical Machinery).
得られた整粒物 3950gにステアリン酸マグネシウム 50gを混合し、これをロータリー 式打錠機 (HP— AP18— SS :畑鐡ェ所)にて、 1錠当たり lOOmgの素錠を製造した 得られた素錠 4000gに、硬ィ匕油 400g、モノステアリン酸グリセリル(-ッコール MG S -B :日光ケミカル) 100g及びモノステアリン酸ポリエチレングリコール(40EO) (二 ッコール MYS— 40 :日光ケミカル) 100gをエタノール 600mLに溶解した液、及びタ ルク 200gを用い、コーティング機(ドリアコ一ター DRC— 650、ノ ゥレック)にて素錠 に防水層を施し、 1錠当たり 120mgのプロテクト掛錠を製造した。  50g of magnesium stearate was mixed with 3950g of the obtained sized product, and lOOmg of uncoated tablets per tablet was produced using this with a rotary tableting machine (HP-AP18-SS: Hata Kyosho). 4,000 g of hard tablet oil, 400 g of hard coconut oil, 100 g of glyceryl monostearate (-KKOR MG S -B: Nikko Chemical) and 100 g of polyethylene glycol monostearate (40EO) (Nikkor MYS-40: Nikko Chemical) in ethanol Using a solution dissolved in 600 mL and 200 g of torque, a waterproof layer was applied to the uncoated tablets with a coating machine (Driacoater DRC-650, Norec) to produce 120 mg of protected locking tablets per tablet.
[0045] <実施例 7> <Example 7>
製造例 3で得たプロテクト掛錠 4800gに、グラニュー糖 1180g、タルク 400g、沈降 炭酸カルシウム 400g、アクリル酸ェチル 'メタクリル酸メチルコポリマー 30%分散液( オイドラギット NE30D:樋口商会) 66. 7g及び精製水 2000gからなる懸濁した糖衣 液を用い、コーティング機(ドリアコ一ター DRC— 650、ノ ゥレック)にて糖衣液を噴 霧しながら乾燥を行い、 1錠当たり 170mgの糖衣錠を得た。なお、コーティング作業 に費やした時間は 1時間であった。  Protected lock obtained in Production Example 3 4800g, Granulated sugar 1180g, Talc 400g, Precipitated calcium carbonate 400g, Ethyl acrylate 'Methyl methacrylate copolymer 30% dispersion (Eudragit NE30D: Higuchi Shokai) 66.7g and purified water 2000g Using the sugar coating liquid suspended from the above, drying was performed while spraying the sugar coating liquid with a coating machine (Driacoater DRC-650, Norrec) to obtain 170 mg sugar coated tablets per tablet. The time spent on the coating work was one hour.
[0046] <実施例 8 > <Example 8>
製造例 3で得たプロテクト掛錠 4800gに、グラニュー糖 1160g、タルク 400g、沈降 炭酸カルシウム 400g、アクリル酸ェチル 'メタクリル酸メチルコポリマー 30%分散液( オイドラギット NE30D :樋口商会) 133. 3g及び精製水 2000gからなる懸濁した糖衣 液を用い、コーティング機(ドリアコ一ター DRC— 650、ノ ゥレック)にて糖衣液を噴 霧しながら乾燥を行い、 1錠当たり 170mgの糖衣錠を得た。なお、コーティング作業 に費やした時間は 1時間であった。 Protected tablet 4800g obtained in Production Example 3 was added to 1160g of granulated sugar, 400g of talc, 400g of precipitated calcium carbonate, 30% dispersion of ethyl acrylate and methyl methacrylate copolymer ( Eudragit NE30D: Higuchi Shokai) 133. Using a suspension of sugar coating liquid consisting of 3 g and 2000 g of purified water, dry it while spraying the sugar coating liquid on a coating machine (Driacoater DRC-650, Norrec). 170 mg dragees were obtained per tablet. The time spent on the coating work was one hour.
[0047] <実施例 9 >  <Example 9>
製造例 3で得たプロテクト掛錠 4800gに、グラニュー糖 1120g、タルク 400g、沈降 炭酸カルシウム 400g、アクリル酸ェチル 'メタクリル酸メチルコポリマー 30%分散液( オイドラギット NE30D :樋口商会) 266. 7g及び精製水 2000gからなる懸濁した糖衣 液を用い、コーティング機(ドリアコ一ター DRC— 650、パゥ  Protected lock obtained in Production Example 3 4800g, Granulated sugar 1120g, Talc 400g, Precipitated calcium carbonate 400g, Ethyl acrylate 'Methyl methacrylate copolymer 30% dispersion (Eudragit NE30D: Higuchi Shokai) 266. 7g and purified water 2000g A coating machine (Driacoater DRC-650,
レック)にて糖衣液を噴霧しながら乾燥を行い、 1錠当たり 170mgの糖衣錠を得た。 なお、コーティング作業に費やした時間は 1時間であった。  The powder was dried while spraying the sugar-coating liquid at REC) to obtain 170 mg of sugar-coated tablets per tablet. The time spent on the coating work was one hour.
[0048] <比較例 5 >  [0048] <Comparative Example 5>
製造例 3で得たプロテクト掛錠 4800gに、グラニュー糖 1160g、タルク 400g、沈降 炭酸カルシウム 400g、ヒドロキシプロピルメチルセルロース 2910 (TC— 5R:信越化 学工業) 40g及び精製水 2000gからなる懸濁した糖衣液を用い、コーティング機(ドリ アコ一ター DRC— 650、ノ ゥレック)にて糖衣液を噴霧しながら乾燥を行い、 1錠当 たり 170mgの糖衣錠を得た。なお、コーティング作業に費やした時間は 1時間であつ た。  Suspended sugar-coating liquid consisting of 1800 g of granulated sugar, 400 g of talc, 400 g of precipitated calcium carbonate, 40 g of hydroxypropylmethylcellulose 2910 (TC-5R: Shin-Etsu Chemical Co., Ltd.) and 2000 g of purified water. Was dried with a coating machine (Drycoater DRC-650, Norec) while spraying the sugar coating liquid, to obtain 170 mg sugar coated tablets per tablet. The time spent on the coating work was one hour.
[0049] <比較例 6 >  [0049] <Comparative Example 6>
製造例 3で得たプロテクト掛錠 4800gに、グラニュー糖 660g、タルク 1100g、沈降 炭酸カルシウム 1100g、アラビアゴム 280g、ゼラチン 60g及び精製水 600gからなる 懸濁した糖衣液を用い、コーティング機(ドリアコ一ター DRC— 650、ノ ゥレック)に て糖衣液の噴霧、蒸らし、乾燥を別々に行う従来の糖衣コーティング方法により、 1錠 当たり 200mgの糖衣錠を得た。なお、コーティング作業に費やした時間は 3. 5時間 であった。  Using the suspended sugar coating liquid consisting of 660 g of granulated sugar, 1100 g of talc, 1100 g of precipitated calcium carbonate, 280 g of gum arabic, 60 g of gelatin and 600 g of purified water, DRC-650, Norec) was used to obtain 200 mg sugar-coated tablets per tablet by the conventional sugar-coating method in which the sugar-coating liquid was sprayed, steamed and dried separately. The time spent on the coating work was 3.5 hours.
[0050] <製造例 4 >  [0050] <Production example 4>
ノ ルプロ酸ナトリウム 3300g、軽質無水ケィ酸 165g及びェチルセルロース 303. 6 gを高速攪拌造粒機 (VG— 25 :バウレック)に投入し、エタノールを加えることで造粒 物を調製した。これを流動層乾燥機 (FLO— 5B :フロイント産業)にて乾燥をし、その 後整粒機 (パワーミル、昭和化学機械)にて乾燥物を整粒した。 3300 g of sodium norproate, 165 g of light anhydrous caustic acid and 303.6 g of ethyl cellulose are put into a high-speed stirring granulator (VG-25: Baurec) and granulated by adding ethanol. A product was prepared. This was dried with a fluidized bed dryer (FLO-5B: Freund Sangyo), and then dried with a granulator (Power Mill, Showa Chemical Machinery).
得られた整粒物 3426gにステアリン酸カルシウム 24gを混合し、これをロータリー式 打錠機 (HP— AP18— SS :畑鐡ェ所)にて、 1錠当たり 230mgの素錠を製造した。 得られた素錠 3220gに、ェチルセルロース 60g、メタクリル酸コポリマー L (Eudragi tLlOO :樋口商会) 30g、クェン酸トリェチル 22. 5g及び軽質無水ケィ酸 22. 5gをェ タノール 1365gに溶解'分散した液を用い、コーティング機(ドリアコ一ター DRC— 6 50、ノ ゥレック)にて素錠に放出制御層を施した後、さらに、ェチルセルロース 60g及 び軽質無水ケィ酸 30gをエタノール 141 Ogに溶解 ·分散した液を用い、コ一ティング 機(ドリアコ一ター DRC— 650、パゥレック)にて放出制御層を施し、 1錠当たり 245 mgの放出制御錠を製造した。  2442 g of calcium stearate was mixed with 3426 g of the obtained sized product, and 230 mg of uncoated tablets per tablet were produced using this with a rotary type tableting machine (HP-AP18-SS: Hata Kyosho). Liquid obtained by dissolving and dispersing 60 g of ethyl cellulose, 30 g of methacrylic acid copolymer L (Eudragi tLlOO: Higuchi Shokai), 22.5 g of triethyl citrate and 22.5 g of light anhydrous caustic acid in 1365 g of ethanol. After applying a controlled release layer to the uncoated tablet using a coating machine (Driacoater DRC-6650, Norec), 60 g of ethyl cellulose and 30 g of light caustic anhydride were further dissolved in 141 Og of ethanol. Using the dispersed liquid, a controlled release layer was applied with a coating machine (Driacoater DRC-650, Purreck) to produce 245 mg controlled release tablets per tablet.
[0051] <実施例 10 > <Example 10>
製造例 4で得た放出制御錠 686gに、グラニュー糖 93g、タルク 3g、沈降炭酸カル シゥム 51g、アクリル酸ェチル 'メタクリル酸メチルコポリマー 30%分散液 (オイドラギッ ト NE30D:樋口商会) 9. 9g及び精製水 135. 6gからなる懸濁した糖衣液を用い、コ 一ティング機 (ノヽイコーター HCT—30N、フロイント産業)にて糖衣液を噴霧しなが ら乾燥を行い、 1錠当たり 295mg (うち糖衣層の質量は 50mg)の糖衣錠を得た。な お、コーティング作業に費やした時間は 40分であった。  686 g of controlled release tablet obtained in Production Example 4, 93 g of granulated sugar, 3 g of talc, 51 g of precipitated calcium carbonate, 30% dispersion of ethyl acrylate and methyl methacrylate copolymer (Eudragit NE30D: Higuchi Shokai) and purification Using a suspended sugar coating solution consisting of 135.6 g of water, spray the sugar coating solution with a coating machine (NOI COATER HCT-30N, Freund Corporation) and dry it, 295 mg per tablet (of which sugar coating layer) The mass was 50 mg). The time spent on the coating work was 40 minutes.
[0052] <実施例 11 > <Example 11>
製造例 4で得た放出制御錠 686gに、グラニュー糖 186g、タルク 6g、沈降炭酸カル シゥム 102g、アクリル酸ェチル 'メタクリル酸メチルコポリマー 30%分散液 (オイドラギ ット NE30D :樋口商会) 20. lg及び精製水 270. 9gからなる懸濁した糖衣液を用い 、コーティング機 (ノヽイコーター HCT— 30N、フロイント産業)にて糖衣液を噴霧しな 力 乾燥を行い、 1錠当たり 345mg (うち糖衣層の質量は lOOmg)の徐放性糖衣錠 を得た。なお、コーティング作業に費やした時間は 75分であった。  686 g of controlled release tablet obtained in Production Example 4, 186 g of granulated sugar, 6 g of talc, 102 g of precipitated calcium carbonate, 30% dispersion of ethyl acrylate and methyl methacrylate copolymer (Eudragit NE30D: Higuchi Shokai) 20. lg and Using a sugar coating liquid that consists of 270.9 g of purified water, spray the sugar coating liquid with a coating machine (NOI COATER HCT-30N, Freund Sangyo) and dry it. 345 mg per tablet (of which the mass of the sugar coating layer) (LOOmg) sustained-release sugar-coated tablets were obtained. The time spent on the coating work was 75 minutes.
[0053] <比較例 7> <Comparative Example 7>
製造例 4で得た放出制御錠 686gに、グラニュー糖 288. 6g、タルク 81. 3g、沈降 炭酸カノレシゥム 122. 7g、アラビアゴム 9. 6g、ゼラチン 4. 5g、ポリオキシエチレン(1 05)ポリオキシプロピレン(5)グリコール 3. 3g及び精製水 180gからなる懸濁した糖 衣液を用い、小型糖衣機 (菊水製作所製)にて糖衣液の噴霧、蒸らし、乾燥を別々に 行う従来の糖衣コーティング方法により、 1錠当たり 415mgの下掛け錠を得た。なお 、このコーティング作業に費やした時間は 300分であった。さらに、グラニュー糖 114 g、酸ィ匕チタン 6g及び精製水 72gからなる懸濁した糖衣液を用い、小型糖衣機 (菊水 製作所製)にて糖衣液の噴霧、蒸らし、乾燥を別々に行う従来の糖衣コーティング方 法により、 1錠当たり 455mgの色掛け錠を得た。なお、このコーティング作業に費やし た時間は 240分であった。最後に、グラニュー糖 15g及び精製水 9gからなる糖衣液 を用い、小型糖衣機 (菊水製作所製)にて糖衣液の噴霧、蒸らし、乾燥を別々に行う 従来の糖衣コーティング方法により、 1錠当たり 460mg (うち糖衣層の質量は 215mg )の糖衣錠を得た。なお、このコーティング作業に費やした時間は 30分であり、すべ てのコーティング作業に費やした合計時間は 570分であった。 686 g of controlled-release tablets obtained in Production Example 4 were mixed with 288.6 g of granulated sugar, 81.3 g of talc, 122.7 g of precipitated canoresic carbonate, 9.6 g of gum arabic, 4.5 g of gelatin, polyoxyethylene (1 05) Conventional spraying, steaming and drying of sugar coating liquid separately using a small sugar coating machine (manufactured by Kikusui Seisakusho) using a suspended sugar coating liquid consisting of 3.3 g of polyoxypropylene (5) glycol and 180 g of purified water By using the sugar coating method, 415 mg of underlay tablets were obtained per tablet. The time spent for this coating operation was 300 minutes. In addition, a conventional sugar coating liquid consisting of 114 g of granulated sugar, 6 g of acid oxytitanium and 72 g of purified water is used to spray, steam and dry the sugar coating liquid separately on a small sugar coating machine (manufactured by Kikusui Seisakusho) According to the sugar coating method, 455 mg colored tablets per tablet were obtained. The time spent for this coating operation was 240 minutes. Finally, using a sugar coating liquid consisting of 15g of granulated sugar and 9g of purified water, spraying, steaming and drying the sugar coating liquid separately using a small sugar coating machine (manufactured by Kikusui Seisakusho) Dragee tablets (of which the sugar coat layer mass was 215 mg) were obtained. The time spent on this coating operation was 30 minutes, and the total time spent on all coating operations was 570 minutes.
[0054] 上記の結果から、糖衣液を噴霧しながら乾燥を同時に行う本発明の製造方法を用 いれば、従来のコーティング方法に比して作業時間を 3分の 1以下に短縮できること が分力 た。また、糖衣錠における糖衣層の重量も 2分の 1〜4分の 1程度にすること ができることも分力つた。  [0054] From the above results, the use of the production method of the present invention in which drying is performed simultaneously with spraying the sugar coating liquid can reduce the working time to one third or less compared with the conventional coating method. It was. In addition, the weight of the sugar-coated layer in sugar-coated tablets can be reduced to about one-half to one-fourth.
[0055] <吸湿性の評価 >  [0055] <Evaluation of hygroscopicity>
実施例 1〜9、比較例 1〜6で得た糖衣錠 10錠を、 25°C-84. 3%の条件で 1時間 、 2時間、 3時間及び 24時間静置した後の質量を測定し、開始時の質量と比較するこ とで吸湿量を測定し、吸湿率 (%)を算出した。また、実施例 10〜11、比較例 7で得 た糖衣錠 10錠を、 40。C— 75%の条件で 3時間、 1曰、 2曰、 3曰、 7曰、 10曰、 14曰 、 21日、 28日及び 30日間静置した後の質量を測定し、上記と同様に吸湿率(%)を 算出した。結果を図 1〜4に示す。  Ten tablets of the sugar-coated tablets obtained in Examples 1 to 9 and Comparative Examples 1 to 6 were measured at 25 ° C-84.3% for 1 hour, 2 hours, 3 hours and 24 hours. Then, the amount of moisture absorption was measured by comparing with the mass at the start, and the moisture absorption rate (%) was calculated. In addition, 40 sugar-coated tablets obtained in Examples 10 to 11 and Comparative Example 7 were used. C—Measure the mass after standing at 75% for 3 hours, 1 曰, 2 曰, 3 曰, 7 曰, 10 曰, 14 曰, 21 days, 28 days and 30 days, as above The moisture absorption rate (%) was calculated. The results are shown in Figs.
吸湿率 (%) = (各時間保管後の 10錠の錠剤質量-開始時の 10錠の錠剤質量) Z 開始時の 10錠の錠剤質量 X 100  Moisture absorption (%) = (10 tablet weight after storage for each time-10 tablet weight at the start) Z 10 tablet weight at the start X 100
[0056] 図 1より、実施例 1〜3の糖衣製剤は、上記条件下に 24時間静置した場合でも、吸 湿率が 0. 1%と低力つた。比較例 1の糖衣製剤は、 3時間静置した場合に、吸湿率 が 0. 2%となり、 24時間静置した場合には 1. 2%近くにまで増加した。また、比較例 2の糖衣製剤は、 24時間静置した場合に吸湿率が 0. 5%程度にまで増加した。 [0056] From FIG. 1, the sugar-coated preparations of Examples 1 to 3 had a low moisture absorption rate of 0.1% even when allowed to stand for 24 hours under the above conditions. The sugar-coated preparation of Comparative Example 1 had a moisture absorption rate of 0.2% when allowed to stand for 3 hours, and increased to nearly 1.2% when allowed to stand for 24 hours. Comparative example The sugar coating formulation of No. 2 increased the moisture absorption rate to about 0.5% when allowed to stand for 24 hours.
[0057] 図 2より、実施例 4〜6の糖衣製剤は、上記条件下に 24時間静置した場合でも、吸 湿率が 0. 1%と低力つた。比較例 3の糖衣製剤は、 3時間静置した場合に、吸湿率 が 0. 4%となり、 24時間静置した場合には 2. 1%近くにまで増加した。また、比較例 4の糖衣製剤は、 24時間静置した場合に吸湿率が 0. 5%程度にまで増加した。 [0057] From FIG. 2, the sugar-coated preparations of Examples 4 to 6 showed a low moisture absorption rate of 0.1% even when allowed to stand for 24 hours under the above conditions. The sugar-coated preparation of Comparative Example 3 had a moisture absorption rate of 0.4% when allowed to stand for 3 hours, and increased to nearly 2.1% when allowed to stand for 24 hours. In addition, the sugar-coated preparation of Comparative Example 4 increased the moisture absorption rate to about 0.5% when allowed to stand for 24 hours.
[0058] 図 3より、実施例 7〜9及び比較例 6の糖衣製剤は、上記条件下に 24時間静置した 場合でも、吸湿率が 0.5%以下と低カゝつた。比較例 5の糖衣製剤は、 3時間静置した 場合に、吸湿率が 1. 3%近くにまで増加し、 24時間静置した場合には 5. 6%近くに まで増加した。 [0058] From Fig. 3, the sugar-coated preparations of Examples 7 to 9 and Comparative Example 6 showed a low moisture absorption rate of 0.5% or less even when allowed to stand for 24 hours under the above conditions. The sugar-coated preparation of Comparative Example 5 increased its moisture absorption rate to near 1.3% when left for 3 hours, and increased to near 5.6% when left for 24 hours.
[0059] 図 4より、実施例 10及び 11の糖衣製剤は、糖衣層の質量が比較例 7と比べそれぞ れ約 4分の 1及び 2分の 1にもかかわらず、 30日後の吸湿率がそれぞれ 2. 0%及び 1 . 0%以下と極めて低力つた。対して比較例 7の糖衣製剤は、 7日後の段階で吸湿率 が 4. 0%近くなり、更に 10日後では錠剤が破裂してしまった。錠剤の破裂はノ レブ 口酸ナトリウムの吸湿性によるものと推察される。  [0059] From Fig. 4, the sugar-coated preparations of Examples 10 and 11 have a moisture absorption rate after 30 days, although the sugar-coated layer mass is about one-quarter and one-half that of Comparative Example 7, respectively. However, they were extremely low at 2.0% and 1.0% or less, respectively. In contrast, the sugar-coated preparation of Comparative Example 7 had a moisture absorption rate of nearly 4.0% after 7 days, and the tablet burst after 10 days. The rupture of the tablet is presumed to be due to the hygroscopic nature of sodium levoleate.
[0060] 以上より、本発明の糖衣液を用いれば、糖衣液を噴霧しながら乾燥を行うコーティ ング方法により糖衣製剤を製造した場合でも、従来の糖衣製剤に比して低吸湿性に 優れる糖衣製剤を得ることが可能であることが分力つた。  [0060] As described above, when the sugar-coating liquid of the present invention is used, even when a sugar-coating preparation is produced by a coating method in which the sugar-coating liquid is dried while spraying the sugar-coating liquid, the sugar-coating is excellent in low hygroscopicity compared with the conventional sugar-coating preparation. It was possible to obtain a formulation.
[0061] <物性の評価 >  [0061] <Evaluation of physical properties>
実施例 1〜9、比較例 1〜6で得た糖衣錠の硬度及び崩壊度を測定した。硬度は、 20錠をとり、 1錠毎、錠剤硬度計 (PHARMATEST社製 PTB— 311E)で錠剤硬度 を測定し、平均値を算出した。崩壊度は、日本薬局方第 15改正に記載されている崩 壊試験法に従い、補助盤を用いて測定した (富山産業社製 崩壊試験器)。試験は 6 錠について行い、その平均値を算出した。結果を表 1〜3に示す。  The hardness and disintegration degree of the sugar-coated tablets obtained in Examples 1 to 9 and Comparative Examples 1 to 6 were measured. The hardness was 20 tablets, and the tablet hardness was measured with a tablet hardness meter (PTB-311E manufactured by PHARMATEST) for each tablet, and the average value was calculated. The degree of disintegration was measured using an auxiliary panel according to the disintegration test method described in the 15th revision of the Japanese Pharmacopoeia (disintegration tester manufactured by Toyama Sangyo Co., Ltd.). The test was conducted on 6 tablets and the average value was calculated. The results are shown in Tables 1-3.
[0062] [表 1] 表 1  [0062] [Table 1] Table 1
実施例 1 実施例 2 実施例 3 比較例 1 比較例 2 硬度 (N ) 1 2 0 . 2 1 4 8 . 6 1 1 6 . 1 7 1 . 6 1 4 2 . 7 崩壊度 (分) 2 2 . 4 2 1 . 0 2 0 . 6 2 9 . 9 3 0 . 9 [0063] 実施例 1〜3の糖衣製剤は、十分な硬度を有し、かつ崩壊性にも優れて ヽた。一方 、比較例 1の糖衣製剤は硬度及び崩壊性共に不十分であった。比較例 2の糖衣製 剤は、高 、硬度を有して!/、たものの崩壊性が不十分であった。 Example 1 Example 2 Example 3 Comparative Example 1 Comparative Example 2 Hardness (N) 1 20.2 0.2 4 4 6 1 1 6. 1 7 1 .6 1 4 2 .7 Disintegration degree (min) 2 2 .4 2 1 .0 2 0 .6 2 9 .9 3 0 .9 [0063] The sugar-coated preparations of Examples 1 to 3 had sufficient hardness and excellent disintegration properties. On the other hand, the sugar-coated preparation of Comparative Example 1 was insufficient in both hardness and disintegration. The sugar coating preparation of Comparative Example 2 had a high hardness and a poor disintegration property.
[0064] [表 2] 表 2  [0064] [Table 2] Table 2
実施例 4 実施例 5 実施例 6 比較例 3 比較例 4 硬度 (N) 1 1 8. 5 1 20. 3 1 2 5. 8 9 1. 8 1 3 8. 5 崩壊度 (分) 2 0. 5 2 2. 3 2 1. 9 2 8. 3 3 2. 1  Example 4 Example 5 Example 6 Comparative Example 3 Comparative Example 4 Hardness (N) 1 1 8. 5 1 20. 3 1 2 5. 8 9 1. 8 1 3 8.5 Disintegration (min) 2 0. 5 2 2. 3 2 1. 9 2 8. 3 3 2. 1
[0065] 実施例 4〜6の糖衣製剤は、十分な硬度を有し、かつ崩壊性にも優れて ヽた。一方 、比較例 3の糖衣製剤は硬度及び崩壊性共に不十分であった。比較例 4の糖衣製 剤は、高 、硬度を有して!/、たものの崩壊性が不十分であった。 [0065] The sugar-coated preparations of Examples 4 to 6 had sufficient hardness and excellent disintegration properties. On the other hand, the sugar-coated preparation of Comparative Example 3 was insufficient in both hardness and disintegration. The sugar-coating preparation of Comparative Example 4 had high and hardness! /, And the disintegration property was insufficient.
[0066] [表 3] 表 3  [0066] [Table 3] Table 3
実施例 7 実施例 8 実施例 9 比較例 5 比較例 6 硬度 (N) 7 2. 8 7 6. 5 8 1. 8 5 9. 8 9 2. 9 崩壊度 (分) 1 2. 1 1 1. 5 1 2. 2 1 1. 9 1 8. 5  Example 7 Example 8 Example 9 Comparative Example 5 Comparative Example 6 Hardness (N) 7 2. 8 7 6. 5 8 1. 8 5 9. 8 9 2.9 Disintegration degree (min) 1 2. 1 1 1 .5 1 2. 2 1 1. 9 1 8. 5
[0067] 実施例 7〜9の糖衣製剤は、十分な硬度を有し、かつ崩壊性にも優れて ヽた。一方 、比較例 5及び 6の糖衣製剤は硬度または崩壊性が不十分であった。 [0067] The sugar-coated preparations of Examples 7 to 9 had sufficient hardness and excellent disintegration properties. On the other hand, the sugar-coated preparations of Comparative Examples 5 and 6 were insufficient in hardness or disintegration.
[0068] 以上より、本発明の糖衣製剤は、十分な硬度を有し、かつ崩壊性にも優れているこ とが分力つた。  [0068] From the above, it was found that the sugar-coated preparation of the present invention has sufficient hardness and excellent disintegration properties.
[0069] <臭いの評価 >  [0069] <Odor evaluation>
実施例 4〜9、比較例 3〜6で得た糖衣錠の臭いについて評価した。得られた製剤 を透明なガラス瓶に入れ密栓後、 60°Cの条件下で、 3日、 1週間及び 2週間保存した ときの臭いの発生について、 0:薬物由来の不快臭を全く感じない、 1:薬物由来の不 快臭を殆ど感じない、 2:薬物由来の不快臭を感じる、 3:薬物由来の不快臭を強く感 じる、の 4段階で評価した。評価は 5人で行い、平均値を算出した。結果を表 4〜5〖こ 示す。 [0070] [表 4] 表 4 The odor of the sugar-coated tablets obtained in Examples 4 to 9 and Comparative Examples 3 to 6 was evaluated. About the generation of odor when the obtained preparation is stored in a transparent glass bottle and sealed at 60 ° C for 3 days, 1 week, and 2 weeks. 0: No unpleasant odor derived from the drug is felt. The evaluation was made on a four-point scale: 1: feel almost no unpleasant odor derived from drugs, 2: feel unpleasant odor derived from drugs, and 3: feel strongly unpleasant odor derived from drugs. The evaluation was performed by five people and the average value was calculated. The results are shown in Tables 4-5. [0070] [Table 4] Table 4
実施例 4 実施例 5 実施例 6 比較例 3 比較例 4 製造直後 0 0 0 0 0 Example 4 Example 5 Example 6 Comparative Example 3 Comparative Example 4 Immediately after production 0 0 0 0 0
3日後 0 0 0 1 . 2 03 days later 0 0 0 1. 2 0
1週後 0 ◦ 0 2 . 6 01 week later 0 ◦ 0 2.6 6 0
2週後 0 0 0 3 . 0 0 2 weeks later 0 0 0 3. 0 0
[0071] 実施例 4〜6と比較例 4の糖衣製剤は、 2週間の保存期間を経ても、ォキソアミヂン 由来の不快臭を全く感じな力つた。一方、比較例 3の糖衣製剤はォキソアミヂン由来 の不快臭を強く感じた。特に、保存が長期化するにつれて不快臭が強くなることが分 かった。 [0071] The sugar-coated preparations of Examples 4 to 6 and Comparative Example 4 had an unpleasant feeling of unpleasant odor derived from oxoamidin even after a storage period of 2 weeks. On the other hand, the sugar-coated preparation of Comparative Example 3 strongly felt an unpleasant odor derived from oxoamidin. In particular, it was found that the unpleasant odor became stronger as the storage was prolonged.
[0072] [表 5] 表 5  [0072] [Table 5] Table 5
実施例 7 実施例 8 実施例 9 比較例 5 比較例 6 製造直後  Example 7 Example 8 Example 9 Comparative Example 5 Comparative Example 6 Immediately after production
3 日後  3 days later
1週後  One week later
2週後  2 weeks later
[0073] 実施例 7〜9と比較例 6の糖衣製剤は、 2週間の保存期間を経ても、 MMSC由来の 不快臭が殆ど感じられな力つた。一方、比較例 5の糖衣製剤は、 3日後には MMSC由 来の不快臭が感じられ、 1週間後には不快臭が強く感じられた。 [0073] The sugar-coated preparations of Examples 7 to 9 and Comparative Example 6 were strong enough to hardly feel an unpleasant odor derived from MMSC even after a storage period of 2 weeks. On the other hand, the sugar-coated preparation of Comparative Example 5 felt an unpleasant odor due to MMSC after 3 days and a strong unpleasant odor after 1 week.
[0074] 以上より、本発明の糖衣製剤は、従来の糖衣製剤と比べて、防臭性に優れることが 分かった。  [0074] From the above, it was found that the sugar-coated preparations of the present invention were superior in deodorizing properties compared to conventional sugar-coated preparations.
[0075] <製造直後の水分値評価 >  [0075] <Evaluation of moisture value immediately after production>
製造直後の実施例 7〜9、比較例 5〜6の糖衣錠を粉砕し、約 5gを量り採り、反応 試薬として水素化カルシウム用いて、ガス圧水分計により 10分間測定して水分値 (% )を算出した。結果を表 6に示す。  The sugar-coated tablets of Examples 7 to 9 and Comparative Examples 5 to 6 immediately after production were pulverized, weighed about 5 g, measured with a gas pressure moisture meter for 10 minutes using calcium hydride as a reaction reagent, and water content (%) Was calculated. The results are shown in Table 6.
[0076] [表 6] 表 6 [0076] [Table 6] Table 6
実施例 7 実施例 8 実施例 9 比較例 5 比較例 6 水分値(%) 1 . 6 5 1 . 5 5 1 . 6 2 1 . 5 6 2 . 4 8  Example 7 Example 8 Example 9 Comparative example 5 Comparative example 6 Moisture value (%) 1.6 5 1.5 5 5 1.6 2 1.5 5 6 2.4 8
[0077] 実施例 7〜9及び比較例 5の糖衣製剤の水分値 (%)は、比較例 6の糖衣製剤と比 ベて低い数値であった。よって、連続コーティング法を用いると、従来のコーティング 方法に比して、錠剤中の水分値を低くすることが可能であることが分力 た。 [0077] The water content (%) of the sugar-coated preparations of Examples 7 to 9 and Comparative Example 5 were lower than those of the sugar-coated preparation of Comparative Example 6. Therefore, it was found that the moisture value in the tablet can be lowered by using the continuous coating method as compared with the conventional coating method.
[0078] <溶出試験 >  [0078] <Dissolution test>
実施例 11の糖衣錠の溶出試験を行った。試験は、日本薬局方溶出試験法第二法 (パドル法)により、試験液として日局一般試験法崩壊試験法第 2液 500mLを用いて 、毎分 lOOrpmで行った。各時間毎にサンプリングを行い、サンプリング溶液中のバ ルプロ酸ナトリウムを HPLCにて定量し、パルプ口酸ナトリウムの溶出率(%)を算出し たた。結果を図 5に示す。  The dissolution test of the sugar-coated tablets of Example 11 was performed. The test was conducted at lOOrpm per minute using the Japanese Pharmacopoeia Dissolution Test Method 2 (Paddle Method) using 500 mL of the Japanese Pharmacopoeia General Test Method Disintegration Test Method 2 as the test solution. Sampling was performed every hour, and sodium valproate in the sampling solution was quantified by HPLC, and the elution rate (%) of sodium pulp oleate was calculated. The results are shown in FIG.
[0079] 図 5より、本願発明の糖衣製剤は、徐放性にも優れていることが判る。以上より本発 明の糖衣液は、徐放性が求められる薬物のの糖衣製剤化にも有用である。  [0079] FIG. 5 shows that the sugar-coated preparation of the present invention is also excellent in sustained release properties. As described above, the sugar-coating liquid of the present invention is also useful for making a sugar-coating preparation of a drug that requires sustained release.
[0080] 以上より、本発明の糖衣製剤は、連続コーティング法により製造された従来の糖衣 製剤と比べて、十分な硬度を有し、かつ低吸湿性、防臭性に優れる製剤であり、糖衣 コーティング法により製造された従来の糖衣製剤と比べて、短時間のコーティング作 業で製造でき、製造直後の水分値が低ぐ崩壊性に優れる製剤であることが分かつ た。  [0080] As described above, the sugar-coated preparation of the present invention is a preparation that has sufficient hardness and is excellent in low hygroscopicity and deodorization as compared with conventional sugar-coated preparations produced by a continuous coating method. Compared with conventional sugar-coating preparations manufactured by the method, it was found that the preparations can be manufactured with a short coating process, have a low water content immediately after manufacture, and have excellent disintegration properties.
すなわち、本発明の製造方法によれば、糖衣層が薄いにも関わらず十分な硬度を 有し、かつ製造直後の低水分性、低吸湿性、崩壊性、防臭性に優れる糖衣製剤を短 時間かつ簡易に製造することができる。  That is, according to the production method of the present invention, a sugar-coating preparation having sufficient hardness despite its thin sugar-coating layer and excellent in low moisture, low hygroscopicity, disintegration, and deodorization immediately after production can be obtained in a short time. And it can manufacture easily.
産業上の利用の可能性  Industrial applicability
[0081] 本発明の糖衣液を用いれば、糖衣液の噴霧工程、及び乾燥工程を同時に行う連 続コーティング法により糖衣製剤の製造を行うことが可能である。すなわち、煩雑なェ 程を必要とせずに短時間で、低酸素透過性、低吸湿性、防臭性、崩壊性に優れた糖 衣製剤を製造することができる。また、本発明の製造方法は、薄い糖衣層を形成する ことが可能であることから、糖衣液の使用量の削減、製剤の小型化に大いに寄与す る。 [0081] By using the sugar-coating liquid of the present invention, it is possible to produce a sugar-coating preparation by a continuous coating method in which the spraying process and the drying process of the sugar-coating liquid are performed simultaneously. That is, a sugar-coating preparation excellent in low oxygen permeability, low hygroscopicity, deodorization and disintegration can be produced in a short time without requiring a complicated process. The production method of the present invention forms a thin sugar coating layer. Therefore, it greatly contributes to reducing the amount of sugar-coating liquid used and miniaturizing the preparation.

Claims

請求の範囲 The scope of the claims
[1] 糖、アクリル酸ェチル 'メタクリル酸メチルコポリマー及び溶剤を含む糖衣液であつ て、アクリル酸ェチル 'メタクリル酸メチルコポリマーの濃度力 全固形分に対して 0. 0 [1] A sugar-coating solution containing sugar, ethyl acrylate 'methyl methacrylate copolymer and solvent, and the concentration power of ethyl acrylate' methyl methacrylate copolymer is 0.0 against the total solid content.
1〜 10重量%である糖衣液。 Sugar-coating liquid that is 1-10% by weight.
[2] 薬物を含む芯材、並びに該芯材を被覆する糖衣層を有する糖衣製剤であって、該 糖衣層の少なくとも 1つ力 糖及びアクリル酸ェチル ·メタクリル酸メチルコポリマー 0.[2] A sugar-coating preparation having a core material containing a drug and a sugar-coating layer covering the core material, wherein at least one of the sugar-coating layers is sugar and ethyl acrylate / methyl methacrylate copolymer 0.
01〜10重量%を含むことを特徴とする、糖衣製剤。 A sugar-coating preparation, comprising 01 to 10% by weight.
[3] 更に放出制御層を有することを特徴とする、請求項 2に記載の糖衣製剤。 [3] The sugar-coated preparation according to claim 2, further comprising a controlled release layer.
[4] 薬物が、不快な臭!、を有する薬物、水分に不安定な薬物、又はウイスカーを発生 する薬物であることを特徴とする、請求項 2または 3に記載の糖衣製剤。 [4] The sugar-coated preparation according to claim 2 or 3, wherein the drug is a drug having an unpleasant odor !, a drug unstable to water, or a drug generating whisker.
[5] 請求項 1に記載の糖衣液の噴霧工程、及び乾燥工程を同時に行うことを特徴とす る、糖衣製剤の製造方法。 [5] A method for producing a sugar-coating preparation, wherein the spraying step and the drying step of the sugar-coating liquid according to claim 1 are performed simultaneously.
PCT/JP2007/064152 2006-07-25 2007-07-18 Sugar-coated preparation and process for producing the same WO2008013084A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN2007800281535A CN101495101B (en) 2006-07-25 2007-07-18 Sugar-coated preparation and process for producing the same
JP2008526734A JPWO2008013084A1 (en) 2006-07-25 2007-07-18 Sugar coating preparation and method for producing the same
HK09110763.5A HK1132664A1 (en) 2006-07-25 2009-11-17 Sugar-coated preparation and process for producing the same

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP2006-201731 2006-07-25
JP2006201731 2006-07-25
JP2006308050 2006-11-14
JP2006-308050 2006-11-14
JP2006338547 2006-12-15
JP2006-338547 2006-12-15
JP2007132001 2007-05-17
JP2007-132001 2007-05-17

Publications (1)

Publication Number Publication Date
WO2008013084A1 true WO2008013084A1 (en) 2008-01-31

Family

ID=38981396

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/064152 WO2008013084A1 (en) 2006-07-25 2007-07-18 Sugar-coated preparation and process for producing the same

Country Status (6)

Country Link
JP (3) JPWO2008013084A1 (en)
KR (1) KR20090037951A (en)
CN (1) CN101495101B (en)
HK (1) HK1132664A1 (en)
TW (1) TW200812571A (en)
WO (1) WO2008013084A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011063627A (en) * 2010-08-31 2011-03-31 Kyowa Hakko Kirin Co Ltd Granule and orally disintegrable tablet containing medicine having bitterness
CN104367625A (en) * 2014-11-03 2015-02-25 成都森科制药有限公司 Method for preparing selfheal tablet

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3067567B1 (en) * 2017-06-19 2019-07-05 Roquette Freres NEW DRAGEIFICATION PROCESS AND DRAGED SOLID FORMS HAVING IRREGULAR SHAPES

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5163926A (en) * 1974-10-17 1976-06-02 Roehm Gmbh Shokyujoyakuzaino seiho
JP2004010611A (en) * 2002-06-06 2004-01-15 Nisshin Yakuhin Kogyo Kk Masking composition
WO2004108164A1 (en) * 2003-06-04 2004-12-16 Kyowa Hakko Kogyo Co., Ltd. Composition for coating and coated preparation
WO2005039542A1 (en) * 2003-10-27 2005-05-06 Yamanouchi Pharmaceutical Co., Ltd. Drug-containing coated microparticle for orally disintegrating tablet
WO2005120466A2 (en) * 2004-06-07 2005-12-22 Wyeth Sugar coatings and methods therefor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS5244224A (en) * 1975-10-01 1977-04-07 Yamanouchi Pharmaceut Co Ltd Printing on sugar-coated tablets
CH666405A5 (en) * 1985-06-24 1988-07-29 Ciba Geigy Ag SOLID, DURABLE PHARMACEUTICAL FORMS WITH ELASTIC FILM COVER.
DE19615812A1 (en) * 1996-04-20 1997-10-23 Boehringer Mannheim Gmbh Pharmaceutical preparation containing diphosphonic acids for oral administration
JP2004155656A (en) * 2002-11-01 2004-06-03 Kao Corp Sugar-coated tablet

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5163926A (en) * 1974-10-17 1976-06-02 Roehm Gmbh Shokyujoyakuzaino seiho
JP2004010611A (en) * 2002-06-06 2004-01-15 Nisshin Yakuhin Kogyo Kk Masking composition
WO2004108164A1 (en) * 2003-06-04 2004-12-16 Kyowa Hakko Kogyo Co., Ltd. Composition for coating and coated preparation
WO2005039542A1 (en) * 2003-10-27 2005-05-06 Yamanouchi Pharmaceutical Co., Ltd. Drug-containing coated microparticle for orally disintegrating tablet
WO2005120466A2 (en) * 2004-06-07 2005-12-22 Wyeth Sugar coatings and methods therefor

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011063627A (en) * 2010-08-31 2011-03-31 Kyowa Hakko Kirin Co Ltd Granule and orally disintegrable tablet containing medicine having bitterness
WO2012029348A1 (en) * 2010-08-31 2012-03-08 協和発酵キリン株式会社 Granules containing bitter drug and orally disintegrating tablet
CN104367625A (en) * 2014-11-03 2015-02-25 成都森科制药有限公司 Method for preparing selfheal tablet

Also Published As

Publication number Publication date
CN101495101A (en) 2009-07-29
CN101495101B (en) 2012-02-29
JPWO2008013084A1 (en) 2009-12-17
JP2013100365A (en) 2013-05-23
TW200812571A (en) 2008-03-16
JP2014221847A (en) 2014-11-27
KR20090037951A (en) 2009-04-16
HK1132664A1 (en) 2010-03-05

Similar Documents

Publication Publication Date Title
CN101987081B (en) Controlled release preparation
JP6092936B2 (en) Method for producing orally disintegrating tablets
JP4019374B2 (en) Composition containing sustained-release fine particles for rapidly disintegrating tablets in the oral cavity and method for producing the same
KR101465803B1 (en) Orally disintegratable tablet
JP2017125049A (en) Rapidly disintegrating, solid coated dosage form
JP2004277426A (en) Composition containing sucralose
JP5956475B2 (en) Orally disintegrating tablets containing bitter mask granules
WO2007074856A1 (en) Method of producing solid preparation disintegrating in the oral cavity
WO2014181390A1 (en) Functional polymer film-coated particle having high drug content, tablet containing same, and methods for production thereof
CN105832687A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
CN109996542A (en) Oral disnitegration tablet comprising diamine derivative
JP6768984B2 (en) Zinc acetate hydrate tablet and its manufacturing method
CN109010361B (en) Calcichew D3 preparation and preparation method thereof
JP2014221847A (en) Sugar-coated preparation and method for producing the same
CN102458475A (en) Dry-coated orally-disintegrating tablet
CN1961868A (en) A rapidly disintegrating tablet of acid sensitive drug
JP6812104B2 (en) Oral solid composition
JP3746524B2 (en) Antacid composition and pharmaceutical composition using the same
JPH0334928A (en) Oral administration preparation for treating ulcerative colitis and crohn&#39;s disease
KR20170001786A (en) Preparation method for pharmaceutical composition comprising Pelargonium sidoides extracts
JP5248060B2 (en) Sugar-coated preparation containing silicone and method for producing the same
JP2022144779A (en) Coated solid pharmaceutical preparation
JP2022072050A (en) Orally disintegrating tablet containing edoxaban
JP2020070287A (en) Orally disintegrable tablets and methods of making the same
JP2019081757A (en) Method for producing solid preparation

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780028153.5

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07790907

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2008526734

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 1020097003600

Country of ref document: KR

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07790907

Country of ref document: EP

Kind code of ref document: A1